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D. Abstract 
 
Objectives: To systematically explore the perceptions parents and clinicians have of the 
informed consent process in neonatal research.  
 
Methods: A comprehensive literature review of peer reviewed studies, all of which are 
related to the topic of this dissertation. Additionally, an original questionnaire based 
study was conducted. The study recruited parents of newborn infants who had been an 
inpatient of the Neonatal Intensive Care Unit of the Cork University Maternity Hospital 
and clinicians currently employed in either a paediatric or neonatal setting.  
 
Results: Parent perception of informed consent in neonatal research is a relatively well 
studied area. Parents have a lack of understating of certain study procedures including 
the element of randomisation. 72% of clinicians believe approaching parents antenatally 
with information about a neonatal study leads to a greater uptake in consent and 57% of 
parents stated a preference to being approached with information prior to the birth of 
their baby. Parents expressed confusion to some content in the consent forms and junior 
clinicians expressed a lack of understanding of good clinical practice. Parental 
vulnerability during the informed consent process was highlighted.  
 
Discussion/conclusion: Parents are generally supportive of neonatal research. They are 
aware of their vulnerability during the neonatal period. They take part in neonatal studies 
for altruistic reasons such as helping babies of the future and stressed the importance of 
protecting parents in a similar situation. There is a need for increased consultant support 
during the informed consent process for parents and junior clinicians. It is essential junior 
clinicians receive training in the acquisition of informed consent from senior colleagues. 
The establishment of consenting guidelines for junior doctors to assist them during in the 
informed consent process is recommended. There is a need for further research to be 
completed in this complex legal and ethical area to ensure valid, informed consent is 
obtained and to enhance the consenting experience for this vulnerable cohort. 
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Chapter 1: Background and Literature Review 
 
1.1 What is consent 
  
Consent, except in unusual circumstances is an indispensible requirement of ethical and 
lawful medical treatment or research and is considered a key element of clinical practice 
(1). If a clinician chooses to examine, treat or operate on a person without firstly 
obtaining a valid consent (in a situation where consent should have been sought) then 
that clinician has committed an unlawful act (1). To treat patients without their consent is 
a breach of their constitutional rights and transgresses a primary principle of medical law 
(2).  
 
1.2 Informed consent in clinical research  
 
The process of informed consent, as described in national and international guidelines 
state that certain measures must be followed to ensure a research participant has made 
an informed decision about their participation in a research study (3-6). In order for 
consent to be considered valid research participants should receive necessary 
information about a research study, must display an obvious competency for  
understanding the information and also have adequately understood the information and 
finally, must be allowed to make their decision free from coercion, undue influence, 
inducement or intimidation (4).  
 
Certain situations will render it impossible for valid informed consent to be obtained. 
Examples include the age of the potential research participant (a newborn baby is unable 
to give their consent to a research study) and those lacking mental capacity (7).  
 
Obtaining valid informed consent from research participants is key to conducting ethical 
research and is also a legal requirement of clinical research (8). It is the legal and ethical 
duty of investigators to ensure valid informed consent is acquired from parent(s) or 
guardian(s).  
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1.3 Elements of valid informed consent 
 
There are three (3) fundamental components of informed consent which must be present 
for consent to be considered valid. These are voluntariness of consent, an individual’s 
capacity to consent and disclosure of relevant information to that individual (1); 
 
1. The concept of voluntariness is one which highlights the absence of outside 
pressure and manipulation by others during a research participants decision 
making process to clinical research (9). When a decision regarding participation to 
a research study is not deemed voluntary it cannot be considered that valid 
informed consent was obtained (1). 
 
2.  A person is considered to have the capacity to consent to a research study 
provided sufficient capacity is proven in terms of their age and mental capacity 
(1). It has been noted that there is a general assumption that a person can be 
considered competent unless there is a reason to question that presumption (such 
as age or mental capacity) (9).  
 
3. Disclosure of relevant information relating to a research study ensures the 
potential research participant has sufficient knowledge of the research study to 
allow them make an informed decision about consenting or refusing consent to 
that study (1).  
 
It is essential that investigators discuss all study procedures, including risk benefit ratio 
with research participants/proxy consenters during the consent process.   
 
1.4 When informed consent should be sought in clinical research 
 
Informed consent in clinical research adheres to the same medical and ethical principles 
of informed consent in medical treatment. Informed consent should always be sought 
from a research participant prior to any procedure being performed (10).   
 
1.5 Clinical research and informed consent in minors 
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In accordance with the Non-Fatal Offences against the Person Act (1997) the age in which 
a minor can give consent to a medical treatment is 16  (11). In clinical research the 
definition of a minor is a person under the age of 16 years (12). It is a requirement of all 
clinical research studies involving minors that proxy consent is obtained from the 
parent(s) or guardian(s) of the minor.  
 
There are certain requirements of the consenting process which must be adhered to by 
clinicians and investigators engaging in the proxy consenting process. If a minor is of a 
certain age which allows them to engage in discussions about their participation in a 
research study the minor must make an expressed wish to take part in that particular 
study. Investigators must ensure the minor has received adequate information about the 
study according to their mental capacity or level of understanding. This information must 
be given to the minor from research staff with experience in dealing with minor patients.  
 
Like adult participants minors must be informed of the potential risks and benefits of the 
research study during the consenting discussion (12).  
 
It is essential that parent(s) or guardian(s) acting as proxy consenters have the capacity 
understand information received about the study. This will ensure they make an informed 
decision regarding participation or refusal of consent on behalf of the minor (13).  
 
1.6 Informed consent and neonatal research 
 
Informed consent in neonatal research remains a sensitive and controversial subject. 
There are several documented reasons for this. The Euricon study,assessed the validity of 
consent obtained in the neonatal setting. Results showed that of 200 parents who took 
part only 30% were found to have given valid consent or refusal of consent (14). This 
study highlighted that an alarming number of parents had issues with one or more of the 
components which constitute a valid consent. Results of this nature add to the theory 
that it is virtually impossible for parents to have full comprehension of information 
received during the consenting process whilst in a situation where they are experiencing 
severe emotional distress (15). 
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The element of randomisation in a clinical trial can cause confusion amongst parents (16, 
17). Where clinical equipoise is present, a randomised control trial presents the 
opportunity to answer important clinical questions in a non biased fashion. Clinical 
equipoise can only exist when investigators have a genuine uncertainty regarding the 
comparative therapeutic benefit of each arm in a clinical trial (18). Randomisation occurs 
when research participants are randomly assigned to receive one of two different 
treatment arms (one of which may be a placebo). It is generally accepted that random 
allocation of a study treatment/drug is methodologically appropriate however it’s 
application has caused much debate amongst healthcare professionals and ethicists (16). 
It has been suggested that parents are so apprehensive about the wellbeing of their 
newborn that they are not competent to give valid informed consent and that consent 
given may not be truly voluntary (19).  
 
It is the responsibility of investigators who conduct clinical research to ensure compliance 
of the core ethical principles which govern research involving human study subjects. 
These core principles are outlined in the Belmont Report (20). This includes ensuring that 
a valid informed consent is obtained from all research participants. In the case of 
neonatal research, it can prove difficult for investigators to allocate sufficient time to 
parents during the consenting process, particularly if antenatal consent is required. 
Protocols completed for neonatal studies usually include strict timelines for obtaining 
consent, screening and ultimately enrolling newborn babies. Investigators responsible for 
acquiring informed consent are also frequently part of the clinical team caring who care 
for newborn infants. This would mean that the time for which they can allocate to the 
consenting process with the parents may be limited depending on severity of illness of 
the newborn.   
 
It is clear that if improvements are to be made in the quality of the clinical care given to 
sick newborn infants there is a need for clinical research studies (21). Drazen et al. (2013) 
suggests that without clinical research studies neonatologists would be guessing what the 
best treatment is for extremely premature infants rather than actually knowing (22). 
While research exploring into the perceptions of the informed consenting process in 
neonatal research is gaining momentum, it is clear that further research is needed into 
this sensitive and complex area.  
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1.7 Aim/objectives of literature review 
 
The aim of this literature review is to provide the reader with an outline of the 
perceptions and experiences parents and clinicians have regarding the informed consent 
process in neonatal research. 
 
The objectives of this literature review are:   
 
 To extensively review published studies whose main objective was to explore into       
the perceptions/experiences parents and clinicians had of the informed consent 
process in neonatal research;  
 
 To identify and assess key problem areas of informed consent in neonatal  
 research described by parents and clinicians who have been involved in  
              the consenting process and;  
 
 To suggest ways to improve the informed consent experience for parents and 
clinicians after identification of the potential pitfalls in the process as described in 
the literature.  
 
 
1.8 Methods 
 
Study Selection 
 
Selected studies specifically related to parents and clinicians perceptions of the informed 
consent process in neonatal research were chosen. I began my literature search from the 
year 1985. I chose 1985 as this was the year the House of Lords issued their landmark 
ruling on the Gillick Case (23). As a result of the Gillick case, minors (under 16 years) were 
afforded the right to consent or refuse a medical treatment depending on their capacity, 
without the requirement of parental permission (23).  
 
A set of inclusion criteria was developed in order to assist with locating studies directly 
linked to this literature review topic.  
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The inclusion criteria is described in table one below; 
 
Table 1: Inclusion Criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
Search strategy 
 
Initially I completed a Google search to establish the general information available 
regarding parents and clinicians perceptions of informed consent in neonatal research. 
This yielded several articles relating to the topic and provided further information 
regarding the most appropriate online databases to search. With these results I 
conducted searches of the following databases: 
 
Pubmed 
 
To begin I completed a general search entering the following sentence to pubmed; 
“perceptions of informed consent in neonatal research”. This produced 30 results. Of 
these, 9 studies were applicable to my literature review and were free full texts. The 
studies ranged in years from 1997 to 2011. Finally I entered a combination of the 
following words; “clinician’s views, informed consent, neonatal”. This yielded no results.  
 
Inclusion criteria 
English language text only 
Published literature only 
Population: Parents and investigators 
involved in neonatal research studies 
Year: 1985 to 2015 
Primary research directly related to the 
topic (parents and clinicians perceptions of 
the informed consent process in neonatal 
research ) 
16 
 
I then entered a combination of the words “neonatal research, informed consent, 
perceptions”. This search produced 30 results with 9 studies relevant to my literature 
review. However I had previously located all 9 studies in my initial search of pubmed.   
My penultimate search used the following combination of words “neonatal consent, 
randomised controlled trials”. This yielded 129 results and produced 6 new studies to 
review. The studies ranged in years from 1999 to 2011. 
 
For my final search of pubmed I included a combination of the words “informed consent, 
neonatal research”. This yielded 372 results and produced five new studies to review. 
These studies ranged in years from 2005 to 2012.  
 
The Cochrane Library 
 
For my first search I entered a combination of the words “informed consent, neonatal 
research, randomised trial”. This produced two studies relevant to my literature review.  
However both studies had been previously located in my pubmed search. I then carried 
out a second search using a combination of the words “neonatal research, randomised 
trial, informed consent”. This produced two studies, however both had had been located 
in my first Cochrane search.   
 
Google Scholar 
 
I searched Google Scholar from 1985 to 2015 in attempt to locate any studies that may 
have been omitted from the 6 previous searches. I used the following combination of 
words “neonatal research, informed consent, parents views, randomised control trials”. 
This search presented thousands of studies. After reviewing 300 articles it became 
obvious that no further suitable studies would be found. This search yielded three new 
studies relevant to my literature review.  
 
Finally, I conducted a thorough examination of the reference list of each of the 23 key 
studies previously located. This did not produce any new studies relevant to my literature 
review. 
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Table 2: Online database search 
 
1.9 Critical appraisal of studies reviewed  
 
I conducted a critical appraisal of the studies produced from my literature searches. To 
assist with this I utilised the ‘Critical Appraisal Skills Programme’ (CASP) which was 
developed by the Oxford Regional Health Authority in 1993 (24). The core CASP checklists 
(randomised controlled trials & systematic reviews) are based on JAMA 'Users guides to 
the medical literature’ published in 1994 (25). I specifically used the CASP Qualitative 
checklist. A copy of this checklist can be found in appendix two. 
 
A summary of the main findings from the critical appraisal and quality assessment of the 
23 studies included in the literature review is below: 
 
 The aims and objectives of the studies reviewed were clear and comprehensively  
explained; 
 The 23 studies included in the literature review were designed to be either     
interview based, questionnaire based or a combination of both; 
        Each study adequately addressed the aim of the research question (perceptions of   
Electronic 
database 
searched 
Search term(s) used Total number 
of searches 
No. of 
potential 
studies 
located  
No. of 
applicable 
studies 
Pubmed Mesh of the words:  
clinician’s views, informed 
consent, neonatal consent, 
randomised controlled trials. 
Combined words:  
perceptions of informed 
consent in neonatal 
research  
5 561 20 
Cochrane Library Mesh of the words:  
neonatal research, 
randomised trial, informed 
consent 
Combined words:  
informed consent, neonatal 
research, randomised trial 
2 30 2  
(both already 
located in 
pubmed search) 
Google Scholar 
 
 
 
Combined words:  
neonatal research, informed 
consent, parents views, 
randomised control trials  
1 300+  3 
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       informed consent in neonatal research); 
 Two of the studies reviewed had a randomised design. For one study the parents  
              of newborn babies were randomly allocated to receive one of two consenting  
              processes (a standard or enhanced consent) and in the other parents were    
              randomly allocated to receive one of two information leaflets either with or  
              without a standardized verbal explanation; 
 Of the 23 studies reviewed, two studies recruited a parent and clinician  
cohort. The remainder of studies involved a parent cohort only. Each study  
recruited an appropriate cohort to address its research question;  
 All 23 studies included adequate details of the study setting, background  
information and study population (parents, clinicians or both);  
 Demographic data collected ranged from basic (gender, maternal/paternal age,  
gestational age, marital status, race and education) to more detailed data 
collection such as previous birth history, mode of infant delivery, maternal 
medication and condition of mother after birth. The variance in data collected in 
each study was relevant to address the specific research question of each study;    
 Ethical approval was obtained for the majority of studies reviewed. It was unclear  
in one study if ethical approval was necessary or sought however the study did  
discuss ethical considerations when being conducted; 
 Written informed consent was obtained for the majority of studies. One study  
required oral consent only and one questionnaire based study did not seek 
consent from parents as they could refuse to complete the questionnaire; 
 21 of the studies explored into the perceptions parents had of the informed   
consent process in neonatal research and two explored into the perceptions that   
parents and clinicians had of the consenting process;    
 Data analysis was presented and discussed in all studies reviewed. Computer  
analyzing software was used in most studies. All reported data results were  
deemed adequate;   
 Study results and subsequent discussion from the 23 studies reviewed included  
a summary of explicit findings and clear discussion of these findings including 
positive and negative discoveries;   
 The validity of the findings to the research questions asked in each of the studies  
was clear and discussed in the discussion/conclusion section of each study; 
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Table 3: Summary of critically appraised studies, including key findings. 
A brief summary of the 23 studies critically appraised, including key findings can be found in table three below: 
 
Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Wen-Jun Tu et 
al. (2011) 
 
Chinese 
parents on 
research 
participation 
and informed 
consent. 
To understand parents perception 
of the consenting process and how 
they felt the research had affected 
their experience as a parent of a 
sick infant. 
Pilot questionnaire based 
study.  
Sample details: Parents of 
newborn infants admitted 
to the NICU who had 
consented to a neonatal 
clinical trial.  
Approximately one year after 
completing the consenting 
process, a questionnaire, 
letter of information and 
stamped envelope was posted 
to parents. A total of 502 
parents received the 
questionnaire and 206 
completed. 
Parent Parents did not disapprove of the consenting 
process. Parents believe a detailed consent form is 
necessary. Parents want to take part in the 
decision process about enrolling their baby to a 
clinical trial and believe it should not be the sole 
decision of clinicians. 
Marc-Aurele K 
et al. (2012) 
 
Evaluation of 
the Content 
and Process of 
Informed 
Consent 
Discussions for 
Neonatal 
Research. 
An investigation of parental 
perceptions and investigator 
disclosure during the neonatal 
consent process.  
 
 
A pilot, exploratory, 
interview based study. 
Sample details: Parents 
and trial investigators. 
The informed consent 
discussion between 
investigators and parents was 
audio recorded.  
A total of 30 parents and 9 
investigators took part. 
Both Gaps in investigator disclosure and parent 
understanding were found. Parents reported 
comprehension of a greater number of research 
elements than were actually disclosed by 
investigators.   
 
Cartwright et 
al. (2011) 
 
Parent 
perceptions of 
their infant’s 
participation in 
randomized 
controlled 
trials (RCT). 
To explore parents perceptions of 
their infant’s participation in 
randomized control trials (RCTs) 
and the implications of the RCT for 
their infant and themselves. 
A qualitative, interview 
based study.  
Sample details: 16 parents 
of newborn infants who 
participated in clinical trials 
whilst an inpatient in the 
NICU.   
Semi structured interviews 
were conducted with parents. 
Interviews took place either in 
person at their home or over 
the telephone. Interviews 
were audio-taped or digitally 
recorded. 
Parent Parents reported mostly positive experiences 
related to their involvement in the RCTs. Clinicians 
should be encouraged to approach parents about 
enrolment to clinical trials. It was noted that 
appropriate measures should be taken to ensure 
that the individual needs of parents are being met 
throughout the entire research process from 
enrolment to follow-up. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Ballard et al. 
(2011) 
 
Parents 
understanding 
and recall of 
informed 
consent 
information for 
neonatal 
research. 
To measure parent understanding 
and recall of key information they 
received about a phase II neonatal 
clinical trial.  
 
 
A randomised study.  
An enhanced consent 
process was developed to 
determine whether 
parents in the enhanced 
consent group had better 
recall of a phase II 
neonatal clinical trial over 
parents randomised to a 
standard consent process. 
 
Group 1: received the 
standard consenting 
process.  
Group 2: received an 
enhanced consenting 
process. 
60 parents in total (30 in 
control group/30 in enhanced 
consent group). The enhanced 
consent group received extra 
information about the study 
during consent process and 
completed a questionnaire 
immediately after consenting 
to see how much information 
they understood.  
 
Both groups then received a 
follow-up validated 
questionnaire upon their 
infants discharge.  
 
The questionnaire addressed 
their consenting experience 
and recall of the process.  
Parent Key findings from validated follow up 
questionnaire: For most questions there was no 
significant difference in the responses of parents in 
either consent group. 
 
Enhanced Group: Better recall of study 
information relating to the trial, its risks and the 
right to withdraw.  However none of the follow-up 
questionnaire responses from parents in the 
enhanced consent group reflected optimized recall 
of informed consent information.  
 
This study highlighted the presence of the 
therapeutic misconception. Parents believed the 
primary purpose of the clinical trial was to help 
their newborn’s lungs, rather than to obtain 
generalized medical knowledge that might benefit 
the health of other newborns in the future. They 
incorrectly believed taking part in the phase 2 trial 
would directly benefit their baby. 
Ward (2010) 
 
Parents' views 
of involvement 
in concurrent 
research with 
their neonates 
To discover whether parents 
previously asked to enrol their 
newborn to clinical trials would 
have found concurrent research 
about their decision-making overly 
burdensome.  
A qualitative, descriptive, 
interview based study.  
Sample details: Parents of 
critically ill newborns who 
were approached about 
enrolling their infant to a 
clinical trial were asked to 
take part. Parents were 
asked what they believed 
about the potential burden 
or value of being 
interviewed to 
explore/discuss the 
reasons consenting their 
newborn to a clinical trial. 
This was called ‘concurrent 
research’.    
Interviews were audio-
recorded, transcribed, and 
analyzed using content 
analysis techniques. 27 
parents in total consented to 
the interview.  
 
 
Parent Participants considered concurrent research 
acceptable for them but potentially problematic 
for others. Some parents felt discussing concurrent 
research may lead to unintentional coercion   
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Korotchikova 
et al. (2010) 
 
Presence of 
both parents 
during consent 
process in non-
therapeutic 
neonatal 
research 
increases 
positive 
response. 
To investigate factors that 
influenced parental consent/non-
consent in a non-therapeutic 
electroencephalogram (EEG) study 
in healthy newborns. 
Sample details: Parents of 
healthy newborn infants 
were asked to enrol their 
baby in a neonatal EEG 
study. In the case of 
refusing/withdrawing 
consent, an informal 
interview was conducted 
to investigate reasons for 
refusal.  
126 couples were approached 
to participate, 3 mothers were 
excluded due to a language 
barrier. Interviews were 
analysed and grouped 
according to the four 
principles of the consent 
process. 
Parent Parent consent to the study was obtained in 82 
cases. 10 parents subsequently withdrew consent. 
Total number of participating parents was 72. 
Approximately 33% refused to consent their 
newborn baby to the study. Consent was more 
likely to be given if both parents were present. 
When mothers were approached alone, obtaining 
consent was significantly more difficult within the 
first 6 hours of delivery compared to a later 
approach (37% vs. 67% respectively). Refusals 
were classified into issues of voluntariness (7%), 
informed choice (10%), understanding (54%) and 
competence (29%). 
 
Jollye (2009) 
 
An exploratory 
study to 
determine how 
parents decide 
whether to 
enrol their 
infants into 
neonatal 
clinical trials. 
To determine how parents decide 
to enrol their baby into neonatal 
clinical trials. 
Semi structured, interview 
based, qualitative study. 
Sample details: Families 
who had decided to enrol 
or not enrol their baby into 
non urgent clinical trials 
took part.   
 
Parents took part in the 
semi structured  
The semi structured 
interviews took place two 
months after their baby was 
discharged home.  
 
A total of 7 families took part. 
 
Interviews with parents were 
recorded, transcribed and 
analysed using an open coded 
mechanism. 
Parents Parents take a journey during the consenting 
process. They experience many emotions such as 
fear and shock when their baby is admitted to a 
NICU. They expressed shock at being asked to 
enrol their baby to a clinical trial at such an 
emotional time. 
Recommendations: Parents recommend a tour of 
the NICU prior to delivery. 
Parents weighed up the risks and benefits for their 
baby taking part in a trial.  
Parents who decided to take part believed there 
was at no real risk for their baby and were pleased 
to be helping future generations.  
Parents who declined felt the risk was to great and 
felt guilt in reaching this decision.  
Overall for this small study, parents were 
supportive of neonatal research. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Ward (2009) 
 
Chaos, 
vulnerability 
and control: 
parental 
beliefs about 
neonatal 
clinical trials. 
This study examined parents beliefs 
about participating in clinical trials 
which involve a greater than 
minimal risk to their neonate and 
explored into their views of the 
experience. 
A qualitative, descriptive, 
interview based study.  
Sample details: Parents of 
newborn babies in the 
NICU who had been 
approached to consent 
their newborn to research 
were asked to 
describe their decisions 
about consenting or not 
consenting their infant to 
the study.  
A total of 27 parents from 
three different hospitals took 
part.  The majority of 
interviews took place via 
phone and were audio taped.  
 
An interview guide was used 
by the interviewer to ensure 
the same line of inquiry was 
assumed with each 
participant.  
 
Data collection stopped when 
interviews yielded minimal 
new information to expand 
the findings. 
Parent Analysis of interviews yielded 3 key themes: chaos, 
vulnerability and control. Parents expressed fear 
and confusion for their infant. Parents voiced 
perceptions of their own vulnerability, 
acknowledged other parents’ susceptibility and 
showed vulnerability through their 
misunderstandings of the infants research 
protocol.  
Factors influencing a sense of control included the 
time parents believed they had to make a decision, 
gathering information and participation in the trial. 
Hoehn et al. 
(2009)  
 
Parental 
perception of 
time and 
decision-
making in 
neonatal 
research. 
To assess the impact of time on 
parental decision-making for 
research participation of their 
newborn infants with congenital 
heart disease. 
Interview based study.  
Sample details: Parents of 
newborn infants with 
congenital heart disease. 
 
 
Interview based study.  
18 father and 19 mothers 
were interviewed separately  
within 10 days of their 
neonate’s cardiac surgery.  
 
All parents were asked the 
same questions: (1) ‘Did you 
have adequate time to make a 
decision about research?’ and 
(2) ‘Why?’ 
 
Interviews were audio taped 
and transcribed for further 
review and analysis. 
Parent Of the 37 parents, 14 said they had insufficient 
time to make a decision regarding their baby’s 
participation in at least one of the studies however 
some of these parents still permitted their baby to 
be enrolled.  
 
A total of 23 parents reported that they did have 
enough time to make a decision regarding their 
baby’s participation in the studies presented to 
them. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Freer et al. 
(2009) 
 
More 
information, 
less 
understanding: 
a randomized 
study on 
consent issues 
in neonatal 
research. 
To explore the impact of various 
information-sharing approaches on 
parents' understanding of a 
research study and the validity of 
their consent.  
 
Randomized, controlled 
study.  
Sample details: Parents of 
parents of immature but 
well infants admitted to 
the NICU were randomly 
assigned within 72 hours of 
the infant's admission to 
receive 1 of 2 information 
leaflets either with or 
without a standardized 
verbal explanation, for a 
hypothetical intensive care 
research study. Leaflets 
differed in length and in 
the amount of detail in 
which the study process, 
risks, benefits and patient 
rights were described. A 
questionnaire was used to 
elicit parents 
understanding of the 
purpose, design and 
procedures involved in the 
study and the consent 
process. 
Parents were randomly 
assigned to receive 1 of 4 
different styles of information 
leaflets:  group 1 - US leaflet; 
group 2 - US leaflet and 
explanation; group 3 - UK 
leaflet; group 4 - UK leaflet 
and explanation. 
 
Demographic data and 
previous experience with 
neonatal research were 
collected. 
 
A total of 41 parents took 
part. 
 
 
Parent Parents who received the longer leaflet without 
verbal explanation gained only limited 
understanding of the purpose of the research 
study.  
 
Study procedures were understood better by 
those who received the shorter leaflet. Issues 
relating to consent and study design were readily 
understood in all groups.  
 
Irrespective of documentation style, verbal 
explanation significantly improved understanding.  
 
Differences in understanding had little effect on 
whether a parent would enrol his or her infant into 
the study. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Snowdon et al. 
(2006) 
 
"It was a snap 
decision”:  
Parental and 
professional 
perspectives 
on the speed 
of decisions 
about 
participation in 
perinatal 
randomised 
controlled 
trials. 
This study explored the pace of 
decision-making for parents who 
were asked to enrol their newborn 
infant to perintatal or neonatal 
trials. 
 
An interview based 
qualitative study. 
Sample details: Parents of 
infants associated with 
perinatal or neonatal 
clinical research. involving 
78 
The study was conducted in 8 
UK centres and focused on 
two antenatal and two 
neonatal trials. The study 
involved 51 parent interviews 
describing 56 trial-related 
decisions. 78 parents in total 
took part.  
When taking part 62 parents 
had surviving infants and 16 
parents had infants who had 
died. Most interviews were 
conducted in parents’ homes. 
Two were conducted by 
telephone. Interviews were 
tape-recorded with parental 
permission. The transcripts 
were read and coded using 
the textual analysis computer 
package Atlas - ti. 
Parent The themes associated with fast pace decisions 
were concern for their baby, reactions to staff and 
perceptions of the benefits and risks associated 
with the trial. Those who took longer to decide 
whether or not to participate often described 
similar emotions to those who made rapid 
decisions but their slower decisions were because 
more time was available, they wanted further 
discussion or they found the decision particularly 
difficult. The majority of those who made rapid 
decisions felt that there were no risks associated 
with the trial in question in contrast to the 
majority of those who made slower decisions who 
felt there were risks. The parents did not appear to 
view rapid decisions as problematic. Although 
there was evidence of parental vulnerability in 
each trial context, they largely felt that they acted 
swiftly and responsibly in the best interests of 
their child in accordance with the timeframes that 
were set for them. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Morley et al. 
(2005) 
 
What do 
parents think 
about enrolling 
their 
premature 
babies in 
several 
research 
studies? 
To investigate parents' opinions 
about enrolling their premature 
baby into several research studies 
in the few days after birth. 
Questionnaire based 
research study. 
Sample details:  Mothers 
and fathers of preterm 
newborn infants admitted 
to the NICU.  
In total 50 mothers and 42 (of 
48) fathers completed the 
questionnaire independently.  
The newborn infants had been 
asked to join two or more 
studies. Parents were invited 
to complete a questionnaire 
about each study which 
involved their baby. The 
questionnaire was piloted on 
10 sets of parents before final 
modification. There were two 
styles of question. Parents 
were either asked to circle the 
most appropriate answer to 
each question or to answer on 
a seven point likert scale. They 
were to fill in the 
questionnaire during their 
baby’s third week of life. They 
were asked to complete it 
independently of their partner 
and return it anonymously in a 
sealed envelope. 
Parent 71% of the parents thought it was good for their 
baby to be in a hospital which carried out research. 
93% thought their baby would get the same or 
better care in a study. 15% thought their baby was 
too small for research studies. 98% wanted to be 
involved in the decision about their baby joining a 
study. 22% were worried about the number of 
studies. 10% would not enrol their baby in any 
studies. 74% were willing for their baby to join two 
or more studies. 10% would enrol in all the 
studies.94% believed that their baby’s 
participation would improve care of future babies. 
From this study, it appears that parents are 
supportive of neonatal research and participation 
in multiple studies. 
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Author and 
study title 
Study aim Research design  
and sample details 
Data collection  Perception: 
Parent/ 
Clinicians 
or 
both   
Key findings 
Cultbert et al. 
(2005)  
 
Parental 
preferences 
for neonatal  
resuscitation  
research  
consent: a pilot 
study. 
 
This study aimed to evaluate 
parental preferences for 
hypothetical consent 
procedures in neonatal  
resuscitation research. 
Pilot questionnaire based 
study. 
Sample details: Randomly 
selected parents who had 
received obstetrical or 
neonatal care at a tertiary 
perinatal centre.  
Questionnaires were posted 
to parents. The response rate 
was 34%. The respondents 
were a group of highly 
educated women with a 
higher family income than 
would be expected in the 
general population. 
Parents This study showed parent preferences to receive 
prenatal information and consent for studies of 
neonatal resuscitation. A low response rate and 
potentially skewed demographics of the 
respondents prevent generalisability of this result. 
Parents valued the impact the research would 
have on their baby and the importance of a 
positive interaction with the physicians conducting 
the research study. Parents felt most comfortable 
with prospective consent in the setting of prenatal 
classes or prenatal visits with a physician, but they 
were somewhat uncomfortable with 
prospective consent upon admission to hospital 
after labour had begun. Parents were 
uncomfortable with waived consent, 
deferred consent, and opting out. 
 
Hoehn et al. 
(2005) 
 
What factors 
are important 
to parents 
making 
decisions 
about neonatal 
research? 
To determine the reasons for 
parents' decisions about 
participation in research studies. 
Semi structured qualitative 
interviews.  
Sample details: Parents of 
newborn infants.  
 
Qualitative analysis of the 
unsolicited comments of 34 
parents regarding their 
reasons for agreeing or 
declining to participate in 
neonatal research studies. 
 The study represents a 
qualitative analysis of these 
unsolicited and originally 
unanticipated, parental 
comments about research 
participation. All the 
interviews were audio-taped, 
transcribed, and analysed 
using N-Vivo qualitative 
software. The 
transcripts were reviewed 
independently to identify 
parental reasons 
during the interviews. 
 
Parent Parents cited five types of reason for or against 
permitting their newborn to participate in research 
studies: societal benefit (n = 18), individual benefit 
for their infant (n = 16), risk of study participation 
(n = 10), perception that participation posed no 
harm (n = 9), and anti-experimentation views (n = 
4). 
27 
 
 
 
Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Stenson et al. (2004)  
 
Neonatal research: the 
parental perspective. 
To investigate the 
recollections of parents 
consenting for their infants 
to be research subjects and 
determine their views about 
the need for consent. 
Questionnaire based 
research project.  
Sample details: Parents of 
sick infants who had been 
enrolled to a RCT.  
Questionnaire and letter 
was posted to 154 parents, 
18 months after the RCT 
finished.  
 
All parents gave written 
consent and received an 
information leaflet about 
the RCT. 
 
Questionnaire based on 
likert scale and had open 
and closed ended questions 
all regarding their 
experiences of the consent 
process. The questionnaires 
were to be returned by post.  
Parent Response rate was 64% 
(99/154). Some respondents 
(12%) did not remember 
being asked to consent to 
their baby joining a study 
and a further 6% were 
unsure. Most of the 
respondents (79%) were 
happy, 13% neutral, and 8% 
unhappy with their decision 
to give consent. None felt 
heavy pressure to agree. 
Entering the trial caused 
24% of respondents to feel 
more anxious, 56% neutral, 
and 20% less anxious about 
their baby. Most of the 
respondents (83%) would be 
unhappy to forgo the 
consent process for trials 
passed by the institutional 
ethics committee. 
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Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Ballard et al. (2004)  
 
Neonatal research and the 
validity of informed consent 
obtained in the perinatal 
period 
To determine the validity of 
informed consent obtained 
from parents of infants 
enrolled in a multicenter 
randomized research study, 
neurologic outcomes and 
pre-emptive analgesia in the 
neonate (NEOPAIN). 
Interview based study. 
Sample details: Subjects: 
Parents of infants enrolled 
to an RCT.  
 
  
In total 64 parents were 
interviewed by investigators 
either in the NICU or by 
phone.  
 
The questionnaire was 
developed by investigators 
and had open ended 
questions based on a likert 
scale.  
 
Parents were asked 20 open 
ended questions to 
determine their level of 
understanding (including 
memory of consenting) of 
the RCT. 
 
Results were analysed using 
SAS. 
Parent 7.8% of parents had no 
recollection of the NEOPAIN 
study or of signing consent. 
Of those who remembered 
the study, only 67.8% 
understood the purpose of 
the study. A higher 
proportion of the mothers 
than fathers were aware of 
the purpose of the study. Of 
those who understood the 
purpose of the study 95% 
were able to verbalize the 
benefits, but only 5% 
understood any potential 
risks. No parents reported 
feeling pressured or coerced 
to sign consent for the 
project and all parents 
reported they would enrol 
their child in additional 
studies if asked. 
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Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Burgess et al.  
(2003) 
 
Consent for clinical research 
in the neonatal intensive 
care unit: a retrospective 
survey and a prospective 
study. 
To understand parental 
perceptions of the process 
of recruitment and 
enrolment for research in 
the neonatal intensive care 
unit. 
Questionnaire based study. 
Sample details: Parents of  
newborn infants who were 
enrolled in trials in a 
neonatal intensive care unit. 
 
The questionnaire was used 
in both a retrospective and a 
prospective study. 
The questionnaire had 35 
questions based on a likert 
scale. Closed ended and 
open ended questions were 
included as well as 
demographic questions. 
 
It was either posted or given 
to parents who 1; had a 
baby enrolled in a study in 
the NICU in the past or 2; 
parents who at present had 
a baby enrolled in a study in 
the NICU. 29 parents 
completed the retrospective 
study and 44 parents 
completed the prospective 
study. 
Parent The retrospective survey 
had a 79% response rate. 
90% of parents felt that they 
had made informed 
decisions. 93% were 
opposed to allowing doctors 
decide if newborns should 
be enrolled into a study, 
rather than the parent. 38% 
found that recruitment did 
add "stress to an already 
stressful situation".  
 
90% felt that they had made 
informed decisions. Parents 
thought that they would be 
comfortable with enrolment 
into two studies.  
 
Parents suggested that 
information about a study 
be made available to them 
before delivery.  
 
The responses of parents in 
the prospective study were 
mostly consistent with those 
from the retrospective 
survey. 
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Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Singhal et al. (2002)  
 
Parents' perceptions of 
research with newborns. 
To examine beliefs and 
attitudes of parents about 
research with babies. 
Questionnaire based study. 
Sample details: 72 parents 
of newborn babies admitted 
to the in the NICU and 159 
parents of normal 
newborns. 
The questionnaire was 
developed to assess the 
general attitudes of parents 
about research with 
newborns.  
 
In the NICU 72 families 
participated in the study and 
52 returned completed 
questionnaires giving a 
response rate of 72%. A 
total of 207 families with 
normal newborns were 
asked to take part; 166 
agreed and 107 returned 
completed questionnaires 
for a response rate of 64%. 
Parent Parents showed favourable 
attitudes toward research 
with babies. There were few 
differences between the 
two groups of parents, but 
there was a trend toward 
increased trust in doctors by 
"NICU parents."  
 
Couples with newborns in 
the NICU were significantly 
more likely to enrol their 
newborn in a study involving 
moderate risk and possible 
major direct benefit.  
 
Almost a third of the sample 
in both groups was willing to 
enrol their newborn in a 
study with moderate risk 
and no direct benefit. 
Mason et al. (2000)  
 
Obtaining informed consent 
to neonatal randomised 
controlled trials: interviews 
with parents and clinicians 
in the Euricon study. 
Questions have been asked 
about whether the process 
of obtaining informed 
consent from parents to 
clinical trials on neonates 
leads to valid consent. The 
aim of this study was to 
assess this issue and to seek 
any practical improvements. 
Semi-structured interview 
based study. 
 
Sample details: Parents of 
200 babies who had been 
asked for consent to 
neonatal trials and 107 
neonatologists seeking 
consent to neonatal trials.  
Parents and investigators 
were interviewed by 
research assistants.  Most 
questions were open-ended. 
Interviews were taped 
where consent was given 
and telephone interviews 
were also permitted. 
  
For telephone interviews, 
the answers to questions 
were written onto the 
schedules during the 
interview whereas in taped, 
face-to-face interviews 
answers were transcribed 
later onto the schedules by 
the interviewer. 
Both 59 of the 200 parents had 
given valid consent or 
refusal. Impaired consent 
was greatest for research in 
an emergency situation and 
for that associated with risk 
or discomfort greater than 
standard treatment. 
Information sheets were 
little used by parents in 
deciding whether to 
consent.  
 
Parents highly valued their 
involvement in the informed 
consent process, and 
clinicians generally agreed 
on the value of the 
consenting process. 
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Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Oberle et al.(2000)  
 
Development of an 
instrument to investigate 
parents' perceptions of 
research with newborn 
babies. 
The purpose of this study 
was to begin an exploration 
of parents perceptions 
about research with 
newborn babies through the 
development and validation 
of a survey instrument. 
Questionnaire based study.  
Sample details: 72 parents 
with infants in a NICU/SCN 
and 159 parents of normal 
newborn babies. It was 
explained to the parents 
that in order to complete 
part of the questionnaire 
they would be required to 
imagine that their baby was 
ill and that if they 
experienced severe distress 
there would be counselling 
immediately available. 
231 parents completed the 
questionnaire. Descriptive 
statistics were calculated on 
all variables.  
 
The questionnaire looked 
for demographic 
information. The 
questionnaire consisted of 
likert scale questions. The 
final section was developed 
to determine the 
circumstances under 
parents would enrol their 
newborn into a trial. 
Parent Factor analysis revealed 
seven factors corresponding 
to issues identified in the 
literature, providing 
evidence of construct 
validity.  
 
Parents had no difficulty 
completing the instrument 
and all questions were 
answered by the majority of 
participants. It was 
concluded that the 
questionnaire had adequate 
psychometric properties and 
that a mixed method 
approach can be fruitful in 
exploring sensitive issues. 
Snowdon et al. (1999) 
 
Zelen: Attitudes of Parents 
Participating in a Neonatal 
Clinical Trial. 
This study describes how 44 
parents recruited to a 
difficult neonatal trial that 
used conventional 
randomization reacted to 
the idea of Zelen 
randomization. 
Qualitative interview based 
study.  
Sample details: A total of 44 
parents were interviewed 
(including two parents 
present at the interview as 
well as lone parents). Pilot 
study completed initially 
with 8 parents, then main 
study with 36 parents. 
Interviews were carried out 
in parents home or over the 
phone in UK and Ireland. All 
interviews were tape 
recorded with the 
permission of the parents. 
Parents All but 3 parents expressed 
an opinion on Zelen 
randomisation. 
 
21 in favour of Zelen 
randomisation, 20 opposed, 
1 unable to decide and 2 
parents did not give clear 
enough answer regarding 
their feeling toward Zelen to 
be able to distinguish if they 
were for or against it. 
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Author and study 
title 
Study aim Research design  and 
sample details 
Data collection  Perception: 
Parent/ 
Clinicians or 
both   
Key findings 
Zupancic et al. (1997) 
 
Determinants of parental 
authorization for 
involvement of newborn 
infants in clinical trials. 
This study was completed to 
determine the degree to 
which a parental decision to 
enrol their newborn infant 
to a clinical trial is 
influenced by risk and 
benefit considerations 
compared with other 
factors. 
Cross sectional survey.  
Sample details: Parents who 
had recently given or 
declined consent to one of 3 
clinical trials in a NICU. 
124 parents were asked to 
complete the questionnaire 
which consisted of 15 
sociodemographic items and 
13 scaled responses to 
statements assessing the 
probability and magnitude 
of risk and benefit as well as 
perceived illness severity, 
attitudes toward research, 
and the consent process. 
Responses were subjected 
to factor analysis to identify 
underlying constructs. The 
sample was then randomly 
split, and multiple 
regression was performed 
on each half. Response rate 
was 83% (103 of 124) for 
those who had consented 
and 86% (37 of 43) for those 
who had declined. 
Parent In making consent decisions 
on behalf of their newborn 
infants, parents are 
influenced by risk and 
benefit assessments, 
attitudes toward research, 
and the integrity of the 
consent process.  
 
A significant minority of 
parents (32%) would prefer 
to have clinicians advise 
them whether to volunteer 
their infants for a clinical 
trial. 
 
Snowdon et al. (1997) 
 
"Making sense of 
randomization”; responses 
of parents of critically ill 
babies to random allocation 
of treatment in a clinical 
trial. 
To explore in detail parental 
reactions to randomisation 
allocation of treatment in a 
neonatal randomised 
controlled trial involving 
ECMO. 
Two part study involving 
completion of a 
questionnaire and face to 
face interviews. 
Sample details: Parents of 
critically ill newborns 
Parents of critically ill 
newborns were initially 
asked to complete a 
questionnaire which focused 
on their satisfaction relating 
to the information they 
received at the time of 
consent. 71 parents 
returned a completed 
questionnaire. The 
questionnaire enquired if 
parents would like personal 
contact with a researcher. 
42 said yes and 21 couples 
were invited to take part in 
interview part of study. (21 
= 16 couples and 5 
mothers). 
Parent There was some clear 
confusion over 
randomisation and ECMO 
for most if the parents 
interviewed. A subtle 
distortion of the aims of 
randomisation was evident 
in a number of interviews. 
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1.10 Data collection 
 
From each study the aim, design, data collection methods and key findings/conclusions 
were extracted and assessed. I separated the studies to review data that explored the 
perceptions parents had of the informed consent process, then studies which explored 
the perceptions clinicians had of the informed consent process and finally, studies which 
explored the perceptions both groups had of the informed consent process in neonatal 
research.  
 
1.11 Results 
 
My Pubmed search yielded a total of 561 articles. Of these, 20 were applicable to my 
literature review. My Cochrane Library search did not produce any further articles. Finally, 
my Google Scholar search produced a total of three new articles relevant to my literature 
review. In total I had 23 articles to review and analyse. 21 were studies exploring the 
perceptions parents had of the informed consent process and two explored the 
perceptions parents and clinicians had of the informed consent process in neonatal 
research.  
 
1.12 Parent perceptions of informed consent in neonatal research 
 
For this portion of my literature review I read and analysed 23 studies which examined 
parent perceptions of informed consent in neonatal research. Studies included both 
randomised controlled clinical trials and non therapeutic neonatal research.  
 
From my review it appears that in general, parents are supportive of neonatal research 
(26) (27). They expressed altruistic motives for allowing their newborn infant to 
participate in a research study. They believed that their newborn infant’s participation 
will help future generations of sick, newborn infants. Other reasons for allowing their 
newborn infant participate in neonatal research include a belief that participation would 
be of a personal benefit to their newborn infant and the belief that participation in a 
research study posed no harm to their child (28-30).  
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Parents reflected positively toward their experience of the consenting process; in one 
study reviewed, approximately one year after consenting their newborn infant to a 
neonatal clinical trial, parents did not express disapproval of the consenting process they 
had taken part in (31). 
 
A study conducted by Cartwright et al.(2011) enrolled sick premature newborn infants to 
randomised controlled trials. The study had two aims; to investigate the perception 
parents had of their newborn infant’s participation in randomized control trials (RCTs); 
and the implications of the RCT for both their infant and themselves (29).  
 
This study concluded that clinicians should be encouraged to approach parents about 
enrolment to neonatal clinical trials. In turn, parents stated that the ability to make 
decisions on behalf of their newborn infant regarding participation in clinical trials gave 
them some control of medical decision making in an otherwise uncontrolled situation. 
However, the vulnerability of parents was noted and it was highlighted by parents that 
appropriate care should be provided to parents both during a clinical trial and after the 
clinical trial has ended (29).   
 
The vulnerability of parents has been noted by other researchers. In a study completed by 
Ward (2009) parents specifically acknowledged their own vulnerable status and that of 
other parents in the neonatal period. This study also found that parents demonstrated 
confusion relating to their infants research protocol (32). It is clear that parents are aware 
of their own vulnerability and also have a heightened awareness of the vulnerability of 
parents in a similar position them. It could be possible that parents approached with 
information about a neonatal research study, who are fearful for their newborn infants 
health, fearful for themselves as they attempt to make the ‘correct decision’ about 
consenting to a neonatal research study, also experience additional stress relating to 
feelings of concern for other parents in a similar position to themselves. The vulnerability 
of parents and elements which can add additional stress to them is an area within 
neonatal consenting which will probably warrant further research and discussion. 
 
A variety of studies have shown that in general parents want to be involved in the 
decision making process regarding their infant’s participation in neonatal research (14) 
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(26) (31) (19). However in a study carried out in 1997 a significant minority of parents 
(37%) would rather the clinician advise them about whether they should volunteer their 
newborn infant into a clinical trial, rather than making the decision independently (33). It 
should be noted that in this study parents specifically asked for clinician’s advice 
regarding consent. Parents did not want clinicians to make the decision about consenting 
on their behalf.   
 
Parents are not supportive of the concept of a waiver of consent (34). In a study 
completed Stenson et al.(2004) 83% of participants would be unhappy to forgo the 
consent process for trials which were granted approval by a research ethics committee 
(35). It is clear that while parents value the communication they have with clinicians 
regarding their infant’s participation in neonatal research, they feel it necessary to be 
ultimate decision holders.   
 
Ballard et al (2004) suggests it is virtually impossible to obtain a valid informed consent 
during the antenatal/perinatal period (36). In 2009 the University of Kentucky conducted 
the NEOPAIN study. NEOPAIN evaluated the effect of continuous infusion morphine vs 
placebo on the neurologic outcome of premature. Infants enrolled to this clinical trial 
were between 23 to 33 weeks gestational age.  
 
Parents whose newborn infants were enrolled in NEOPAIN and survived to discharge 
were asked to complete a questionnaire to determine their level of understanding about 
NEOPAIN study procedures. Of the 64 parents interviewed, five (7.8%) did not recall the 
study nor signing consent. For those who did remember the study only 68% had 
comprehension of the purpose of the study. Alarmingly, only 5% could name even one 
risk of the study. Using a stringent set of criteria, only 3% of parents were deemed to 
have given valid informed consent (36, 37). This study involved very sick preterm infants 
and parents under severe emotional stress.  
 
The distressing results of the NEOPAIN trial indicate both an urgent need for further 
exploration specifically into the validity of consent currently being obtained from the 
parents of sick preterm newborn infants during the antenatal/perinatal period and the 
need for guidance for clinicians in relation to obtaining a valid consent from this 
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vulnerable population. On a positive note, parents stated in the questionnaire that they 
did not feel pressure or coerced to enrol their newborn infant to the trial and would 
consider taking part in additional studies if requested. This finding also noted in a 
previous study by Morley et al (26).   
 
1.13 Informed Consent Form 
 
According to Wen-Jun Te et al.(2012) parents involved in the consenting process in 
neonatal research should be provided with a detailed informed consent form (31). These 
results directly conflict the results of a study completed in 2009 entitled “More 
information, less understanding: a randomised study on consent issues in neonatal 
research”. For this study the parents of premature infants were randomly assigned to 
receive 1 of 2 information leaflets. The leaflets differed in content and length and one 
leaflet provided greater detail of study procedures.  
 
Results showed that parents who received the longer information leaflet without a verbal 
explanation of study procedures had limited understanding of the purpose of the study. 
Those who received the shorter, more concise leaflet appeared to have a greater 
understanding of study procedures (38). It was also suggested that verbal explanation of 
study procedures significantly increases understanding of the research process for 
parents regardless of the style of information leaflet written documentation (38).  
 
When one compares the results of both studies it becomes clear that further research 
needs to carried out, in particular, to determine the appropriate amount of information 
which should be provided on consent forms. 
 
It has been suggest that oral and written information should be provided to parents 
concurrently at the time of consent (14). It has also been noted that the presence of both 
parents during the consenting process can lead to a higher uptake of consent to neonatal 
research (39).  
 
1.14 Clinicians perceptions of informed consent in neonatal research 
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It is the responsibility of researchers/clinicians to provide detailed information to parents 
about a neonatal research study and, to establish if the information received has been 
processed and understood (21).  However, despite the critical role clinicians have in the 
informed consenting process in neonatal research, there is a lack of studies available 
which explore their views. I located two studies applicable to this section of my literature 
review.  
 
The first study, by Marc-Aurele et al.(2012) explored into the information disclosed by 
investigators to parents and parental perceptions of information received during the 
consenting process in neonatal research (40). A total of 9 Investigators and 30 parents 
took part. Both consented to having the informed consenting discussion audio taped. 
Tapes were analysed for the content disclosed and discussed by both parties during the 
consenting process.  
 
The following results were noted; a total of 10% of Investigators assessed parent recall of 
the information received at the end of the consenting discussion, 71% of Investigators 
asked parents if they had any concerns about the research study, 48% of Investigators 
asked parents if they understood the information received about the study and 38% of 
Investigators provided a summary of the discussion for parents.  
 
These figures highlight an alarmingly low percentage of Investigators who request 
feedback from parents and also provide feedback to parents about the information 
received and discussed during the consenting process. The parents of newborn infants 
eligible to take part neonatal research are both emotional and vulnerable at the time of 
consent. It is essential that Investigators take the time to ensure parents understand the 
information received during the consenting process. It is their duty to ensure adequate 
discussion including a summary of the dialogue is provided to parents where necessary is 
provided.    
 
Parents subsequently completed a questionnaire relating to their research participation 
and level of comfort with the contact between themselves and the Investigator. Results 
were both positive and negative. 100% of parents understood the voluntary nature of the 
research participation, 95% understood the societal benefit of the research, 90% 
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understood that they were free to withdraw from the study at any time and 85% 
understood the possible risks associated with the study. However 58% agreed or strongly 
agreed that discussing their newborn infants participation in a research study was 
stressful. It is also important to note that only 50% of parents expressed understanding of 
the randomisation process (where randomisation was part of the research study).   
 
Parental confusion surrounding the element of randomisation was highlighted in another 
study completed by Snowdon et al (1997).  In this study clear confusion relating to the 
process of randomization was noted by researchers (16).  
 
It is clear there is a need for further research in this area to be completed to try to 
understand why some parents can find discussing neonatal research with investigators 
stressfull.. It is essential the neonatal community attempt to minimise if not eliminate any 
extra burden clinical research may have on parents.   
 
The second study applicable to this literature review was completed by the Euricon Study 
Group (41). The Euricon Study was funded by the European Union. The objective of the 
study was to examine informed consent in neonatal research throughout European 
clinical sites (42). Briefly, the parents of 200 infants and 107 neonatologists involved in 
the consenting process to a neonatal clinical trial were interviewed by research assistants. 
Interviews were analysed to explore the validity of the consenting process focusing on 
four areas; parental competency, information given by Investigators, parental 
understanding of the information received and the voluntariness of the consent.  
 
Results showed only three Investigators were satisfied with the consenting process in 
general and had obtained a satisfactory consent. A total of 79 Investigators indicated 
concerns about the competency of parents. Investigators expressed conflicting views in 
relation to the amount of information that should be made available to parents. In total 
66 Investigators thought parents should receive all information relating to the clinical trial 
whereas 47 Investigators believed certain information should be withheld from parents.   
 
Results generated from this study were quite alarming. Although 79 Investigators 
expressed concern relating to the competency of parents, they proceeded to allow 
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parents consent their newborn infant into a clinical trial. The causes of concern for 
Investigators included the vulnerability parents, who, according to Investigators, at that 
time did not have the ability to make an informed decision about enrolling their newborn 
to a clinical trial. This was due to the lack of knowledge, intellect or emotional state of the 
parents at that particular time of their lives. All of which could lead one to argue that 
Investigators should never approach parents in a neonatal intensive care setting to seek 
their consent if questions can be raised about their capacity to understand information 
received about a neonatal research study. In total 59 parents out of 200 were deemed to 
have provided a valid consent or refusal to a clinical trial. It is suggested that further 
research is warranted in the highly sensitive area of consenting in neonatal research to 
maximise the ability to obtain valid consent from parents. 
 
1.15 Conclusion 
 
It is clear from this literature review that parental perception of informed consent in 
neonatal research is a relatively well investigated and documented area. The views and 
experiences parents have of various types of neonatal research, including randomised 
controlled clinical trials and non interventional neonatal research has been studied (32) 
(43). Certain results were found to be consistent with each other. It is stated in many 
studies that in general parents are supportive of neonatal research (29) (39) (28) (26). 
Parents want to help babies born in the future, by allowing their newborn infant 
participate neonatal research studies and, in most cases parents want to be the sole 
decision makers regarding consent or refusal of consent.    
 
There has also been novel information produced in relation to randomisation in the 
neonatal research setting including Zelen randomisation in a neonatal clinical trial (44). 
Zelen randomisation is a process whereby randomization occurs automatically prior to 
consent being sought from parents. Consent is sought from parents if the infant is 
randomized to an experimental arm of a neonatal randomized controlled trial. Thus 
parents of infants in the control group will remain unaware that randomization has taken 
place.  
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It has been noted that for therapeutic clinical trials, this method of randomisation is 
probably unethical (45). However a study which explored into parents views of zelen 
randomisation results showed that half of the parents who took part were in favour of 
the process (44). Due to the novel nature of zelen randomisation further research into the 
views parents have of the process is warranted. It is also suggested that research into the 
views ethics committees and clinicians have of zelen randomisation should be 
undertaken.  
  
It is clear that ample information is available which relates to the perceptions parents 
have of the informed consent process in neonatal research. However there is an urgent 
need for further exploration of other aspects of informed consent in neonatal research 
including parents understanding of the randomisation process and, as shown by Ballard et 
al.(2011) the appropriate content and amount of content which should be included in the 
informed consent form (46).  
 
The complex ethical issue of the vulnerability of parents during the neonatal period is 
another area in need of further research. A study completed by Snowdon et al. (2006) 
investigated into the speed of decision-making of parents who were asked to enrol their 
newborn infant to either perinatal or neonatal trials. A total of 51 parental interviews 
took place. The 51 interviews described 56 trial related decisions. Evidence of parental 
vulnerability was noted in this study (47).  
 
There is a scarce amount of information available which deal with investigator 
perceptions of the informed consent process in neonatal research. The two studies 
described in this literature review outline important results in relation to investigator 
perceptions; however there are many gaps in this area in need of further exploration.   
 
In the EURICON study Investigators allowed parents to consent their newborn infant to a 
clinical trial despite the fact that Investigators expressed concerns relating to their 
competence. Could it be noted that the Investigators were acting in an unethical manner 
by allowing consent to be given? It was also noted that some Investigators gave limited 
disclosure of information relating to the risks of the trial. The reasons for this was to not 
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cause any further concern to parents at such a vulnerable time but to also to obtain 
consent.  
 
It is clear that Investigators act in a manner which they believe to be in the best interest 
of parents, study subjects and indeed society by carrying out neonatal research. Results 
from this literature review would suggest that increased training in acquiring informed 
consent is necessary for Investigators when consent is being sought from such a 
vulnerable population. There is an obvious lack of such requisite training in published 
studies which obtain perceptions of informed consent from a clinician’s point of view. 
 
This is an area in urgent need of further research. It could also be suggested that a tool to 
assist Investigators assess the validity of consent be produced, for example a checklist 
that the Investigator must complete after the consenting process to check for the areas of 
competence, understanding of information given and the voluntariness of consent. 
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Chapter 2: Ethical and Legal Issues of Informed Consent in Research 
 
2.1 Background to clinical research involving human participants 
 
Clinical research is governed by strict guidelines and regulations whose main objective is 
to protect human study subjects from harm. Before exploring into the regulations 
overseeing clinical and non therapeutic research, it is important to investigate into the 
historical background of clinical research to fully appreciate why such stringent guidelines 
and regulations are in place. Clinical trials involving human study subjects are now strictly 
monitored for compliance by regulatory bodies in the various member states.  
 
There has been a horrifying legacy of unethical exploitation of human research subjects 
by the scientific and medical communities in the past. Victims of unethical research 
studies include some of the most vulnerable citizens of society such as children with 
mental disabilities, prisoners of war and the economically disadvantaged. At no time were 
any of these participants afforded the opportunity of giving informed consent. 
 
The goal of this chapter is to discuss two of the most controversial, unethical clinical trials 
which took place during the twentieth century, the Tuskegee Syphilis Study and the 
Willowbrook State School Experiments. I will also outline the guidelines enacted after the 
atrocities of experiments conducted on prisoners of war in various Nazi Concentration 
Camps during World War 2 came to light during the Nuremberg Trials.   
 
2.2 The Tuskegee Syphilis Experiment  
 
It is a cruel testament to human nature that we possess the ability to take advantage of 
those more vulnerable than ourselves. The Tuskegee syphilis experiment is an 
unfortunate demonstration of such unethical conduct where the fascination of science 
took precedence over the value of human life (48). This federally funded research 
experiment began in 1932 and continued until 1972, was carried out by the United States 
Public Health Service. The study chartered the natural progression of untreated syphilis in 
African/American men living in rural Alabama. Researchers recruited a total of 600 
impoverished males to the study.  
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The research participants were offered incentives to encourage them to take part in the 
study including free physical examinations, free meals, and burial insurance. They were 
not told of their diagnosis of syphilis nor did they receive adequate treatment for the 
disease. This was despite the discovery of penicillin as the “gold standard” treatment for 
syphilis in 1947 (49) (50).  
 
The Tuskegee Syphilis experiment is an abhorrent example of an abuse of power from 
one human to another. Researchers conducted themselves in both an unethical and 
unprofessional manner. They chose to withhold the treatment for syphilis from this 
vulnerable population, whilst all the time having an effective cure to the disease at their 
disposal. The study finally came to a halt in 1972 after a newspaper report was published 
linking the study to unethical practices which led to a review of the study.  
 
The report highlighted gross misconduct by researchers who withheld crucial information 
about the risks of the research study from participants, and in effect, did not acquire 
informed consent. The unethical treatment of research participants in the Tuskegee 
Syphilis experiment resulted in the publication of the infamous Belmont Report in 1978 
(51). The report describes three core principles which govern the ethics of research 
involving humans which should be adhered to (51); 
 
1. Respect for Persons: Research participants should be treated as autonomous 
agents and their autonomy must be respected. However a person classes as 
having diminished autonomy must be protected; 
 
2. Beneficence: In the context of medical research, to act in a beneficent manner 
researchers must do not harm to research participants and maximize possible 
benefits and minimize possible harm to them; and 
 
3. Justice: The report states that the principle of justice allows fair distribution of 
the benefits of research and that people should be treated as equals (51).   
 
2.3 The Willowbrook State School Hepatitis Experiments  
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Unethical conduct of clinical research involving humans was not limited to vulnerable 
adults. During the mid 1950’researchers working in the state funded Willowbrook School, 
New York purposely infected mentally disabled children, aged three to 11 with strains of 
the hepatitis virus in an effort to study the development of the infection (52, 53). 
Researchers also wanted to determine the effectiveness of gamma globulin injections as 
protection against hepatitis.  
 
To facilitate the research, the lead Investigator Dr Saul Krugman established a specialist 
unit in the school for the children participating in the study. The unit offered improved 
living conditions than the main school including higher hygiene standards and improved 
nutrition. Researchers tried to encourage parents to enrol their child to the study by 
offering expedited entry to the school. At the time Willowbrook School was overcrowded 
and with extensive waiting lists.  
 
While ‘consent’ was obtained from parents on behalf of their children, a clear abuse of 
power by researchers is evident. This included the vulnerability of the children and their 
parents, the fact that the children were exposed to procedures which offered no 
therapeutic benefit, the coercion used by researchers to encourage parents to permit 
enrolment of their infant and finally the lack of acquiring an informed consent.  
 
Attempts were made by the researchers to defend the study. Dr Krugman highlighted the 
fact that 90% of the children involved in the study would eventually contract hepatitis and 
studies performed produced important information on the different strains of hepatitis, 
which did eventually advance research for a vaccine (52, 53). While the development of a 
vaccine against the hepatitis virus was assisted by the research, the unethical actions of 
Dr Krugman and his research team were both damning and are undeniable.  
 
Informed consent, as defined by the Nuremberg code states that consent must be given 
free from coercion (54). This crucial element of consent, along with many others, was not 
adhered to during the consenting process therefore it must be assumed that informed 
consent was not obtained from parents of these mentally ill children. 
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2.4 Second World War and the Nuremberg Trials  
 
After the conclusion of the Second World War, the world watched as 23 scientists and 
physicians stood trial in Nuremberg, Germany. They were accused of committing a wide 
range of depraved experiments and procedures on prisoners in concentration camps in 
between 1933 and 1945 (55). All experiments were conducted against the will of prison 
inmates and at no point informed consent was sought for any procedure.  
 
Prison inmates were at the mercy of physicians and scientists, whose actions often 
resulted in the disability, disfigurement and/or death of prisoners. At that time no clear 
regulations existed which governed research on humans in Germany, thus allowing the 
accused to try to justify their actions. Of the 23 scientists and physicians, 15 were found 
guilty of these heinous crimes and the rest acquitted (56), but most importantly the 
Nuremberg Code was drafted.  
 
The Nuremberg Code is a set of 10 guiding principles for researchers taking part in human 
experimentation. The aim of the code is protection of human subjects. It is the duty of 
researchers to adhere to principles set out in the code when performing research on 
human subjects (54). The Nuremberg Code states it is essential that consent to medical 
research be given by a subject on a voluntary basis, free from coercion (57). It is also 
noted in the code that a person must have the capacity to make an informed choice (54). 
Other important principles outlined in the code include the obligation to avoid 
unnecessary harm to subjects and potential benefits to society as a result of research 
undertaken (54).  
 
To further streamline conduct for research involving humans, the Declaration of Helsinki 
was compiled by the World Medical Association in 1964, most recently updated in 
October 2013. The Declaration of Helsinki is a set of ethical principles which aim to 
provide guidance to physicians and staff involved in medical research with human 
subjects (3). This declaration expanded on the principles outlined in the Nuremberg Code 
and linked them to those of the Declaration of Geneva, which requires physicians to put 
the health and wellbeing of their patients first, and to respect them as human beings (58).  
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It also seeks to standardise the conduct of clinical trials within the United States of 
America, Europe and Japan, the principles in the Declaration of Helsinki were 
incorporated into the International Conference on Harmonisation Good Clinical Practice 
Guidelines (ICH GCP) (5) (59).  GCP is a set of globally recognized ethical and scientific 
requirements that must be observed throughout the lifecycle of a clinical trial (60).  
 
Today, the Nuremberg Code, Declaration of Geneva, ICH CGP and Declaration of Helsinki 
provide the bedrock of best practice guidelines, allowing research to be conducted 
ethically and morally in the medical setting. To expand upon this by formally harmonising 
and regulating medical research conduct throughout the European Union (61), the 
European Directive 2001/20/EC was established.  
 
2.5 European Directive 2001/20/EC  
 
The core objective of the European Directive 2001/20/EC is to protect human research 
subjects and to safeguard public health (62). However, it was the duty of each member 
state to formally implement EU 2001/20/EC and members states could adopt the rules 
set out in the directive they saw fit. In 2005, an amendment to the original directive was 
published, namely the European Directive 2005/28/EC (63).  
 
The amendment outlined  specific guidance to Good Clinical Practice procedures in 
regards to investigational medicinal products for human use (63). On the 16th April 2014, 
the European Commission Regulation (EU) No 536/2014) came into force. This new 
regulation superseded the original directive 2001/20/EC and the amendment 2005/28/EC 
(64). It is now a legal requirement that researchers abide by the principles outlined in the 
regulation in order to engage in lawful and ethical clinical trial practices.   
 
2.6 Informed Consent  
 
It is a requirement of the Directive 2001/20/EC that those who are unable to consent to 
medical research due to capacity issues must be afforded special protection by each 
member state (61). This includes minors. The importance of informed consent and 
protection of minors was further strengthened in Regulation (EU) No 536/2014. The 
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Regulation explicitly states that the guidance set out in relation to informed consent in 
Directive 2001/20/EC must be adhered to by all involved in medical research (64).  
 
Research subjects must provide a written informed consent and in the event whereby a 
subject has literacy issues due to age or issues with literacy, appropriate methods of 
recording informed consent must take place. According to the Regulation, it is the 
responsibility of each member state to determine the legally designated representatives 
of both minors and incapacitated persons (64). 
 
2.7 Informed Consent Form 
 
The informed consent form is classed as an Essential Document.  According to ICH GCP 
essential documents are defined as; 
 
 “documents which individually and collectively permit evaluation of the conduct of a 
trial and the quality of the data produced”(5).  
 
 It is a legal and ethical requirement that study subjects receive and sign the form, or, in 
the case of consenting to neonatal research, that those responsible for proxy consent 
receive and sign the form. The objective of the form is to provide information regarding 
the trial and trial procedures to the parents/guardians of the study subject.   
 
The consent form must be written in a language that is understandable to parents of all 
ages. It must be presented using non-medical, scientific or technical language. The 
contents of the form must include (but are not limited to) the following: the purpose of 
the trial, the aspects of the trial that are experimental, reasonably expected benefits, 
alternative procedure(s) that may be available to the subject, trial intervention(s), 
randomisation, and the fact that refusal to take part in the trial will not in any way alter 
the infants clinical care (5).  
 
Investigators must be aware of their duty to parents who may fall into the category of 
vulnerable such as parents with reading difficulties (partial or total illiteracy) or parents 
who do not speak English. Ireland is fast becoming a multinational country with more 
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parents of international backgrounds than ever presenting themselves to the maternity 
hospital setting. In order for researchers to adhere to the governing principles of medical 
research involving humans, they cannot exclude subjects because of language or 
readability problems.  Kuthning et al. (65) states:  
 
“Illiteracy is a critical problem that affects all corners of our earth; it has no boundaries 
and exists among every race and ethnicity, age group, and economic class”.  
 
 If it is not feasible to provide a translated informed consent form to non English speaking 
parents then a translator must be involved in the informed consent process. In the case 
where parents may be partially or completely illiterate, the Investigator must ensure that 
he/she spends enough time speaking to the parents about the study. In these cases, the 
consent form must also be signed by an independent witness. 
 
2.8 Informed Consent in Ireland – A General Overview 
 
On the 01st May 2004 the EU Directive 2001/20/EC was transposed into Irish Law by the 
Minister for Health and Children, Mr Micheál Martin, namely S.I. No. 190/2004 (66). 
Previous to this, clinical trials in Ireland were governed by the ‘Control of Clinical Trials 
Acts 1987 – 1990’ (67). It is both an ethical and legal obligation of researchers to protect 
the rights, well being and confidentiality of those who volunteer to take part in medical 
research.  
 
For those unable to consent themselves (a minor or a person deemed incompetent) 
consent can be given on their behalf. According to the regulations set out in 2004 a child 
is defined as a person aged 16 and under (66).  For this age group a “person with parental 
responsibility” can consent on behalf of the child. “Person with parental  responsibility” 
means a natural or adoptive parent, a guardian, a person who has acted in loco parentis 
to a child or a person having charge or control over a child, where such person is actively 
involved in making decisions affecting the child's welfare (66).  
 
In neonatal research proxy consent to a research study must be given by the parent(s) or 
guardian(s) of research participants. If parents are married it is deemed best practice to 
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have both parents sign the informed consent form. Previously if parents of the newborn 
infant were not married only the mother’s signature was a legal requirement.  
 
On the 06th April 2015 the Children and Family Relationships Act 2015 was published (68). 
The act includes an amendment to the Guardian of Infants Act 1964 (69). The amendment 
serves to strengthen the rights unmarried fathers have to their newborn infant. However 
a mother’s signature remains a prerequisite of neonatal research participation if the 
father of the newborn infant has not been formally named a legal guardian.   
    
An update to S.I. No. 190/2004 was published in 2006. This amendment, outlines 
additional requirements relating to informed consent, specifically that it must be 
obtained from study subjects prior to their participation in a clinical trial (70).  
 
2.9 European Legislation for informed consent in neonatal research 
 
Dalla-Vorgia et al.(2001) published the paper “Overview of European legislation on 
informed consent for neonatal research” (42). The authors presented a summary of the 
regulations which currently govern informed consent in neonatal research. They focused 
on 10 European countries; Denmark, Finland, France, Germany, Greece, Ireland, Norway, 
Spain, Sweden and the United Kingdom. Results highlighted that most countries have 
similar, if not the same informed consenting process. Proxy consent is permitted in all 
countries, either by parents or legal guardians.  
 
In some countries consent to neonatal research can be given from one parent, however in 
Denmark and Germany if custody of the infant is shared by both parents’ or legal 
guardians then both must provide written consent. In France and Sweden it is deemed 
best practice to obtain consent from both parents prior to the initiation of a research 
study and the case of consent to treatment for emergency research a waiver of consent is 
generally acceptable as part of emergency care. A waiver of consent in that situation is  
not permissible in Ireland and Denmark.  
 
In general, it is a requirement in the ten countries that there must be a potential direct 
benefit for the newborn infants who enter into a research study. However research that is 
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of no direct benefit to newborn infants is permissible with the stipulation that the 
research study involves no more than a minimal risk to the newborn infant (42).  
 
2.10 Research Ethics Committees 
 
The 1975 revision to the Declaration of Helsinki stipulated that research involving human 
subjects should be approved by an independent research ethics committee (71). The 
function and responsibilities of research ethics committees was further harmonised 
across Europe with the publication of the EU Directive 2001/20/EC (61). According to this 
Directive an ‘Ethics Committee’ is an independent body whose function is to protect the 
rights, safety and wellbeing of human subjects involved in clinical trials.  
 
Ethics Committees consist of healthcare professionals and lay members who oversee the 
ethical conduct of a clinical trial (61). In all jurisdictions it is a legal requirement that 
Investigators seek approval from either their local or national Ethics Committee. It varies 
between members states as to whether local or national approval must be sought. 
Regardless of the member state and its own regulations pertaining to ethics committees, 
Investigators must seek permission from the committee prior to initiating any type of 
research study.  
 
2.11 Conclusion  
 
Since the end of World War 2, informed consent in clinical and non therapeutic research 
has become a highly controlled and regulated aspect of human experimentation. Extra 
protection has been afforded to those classed as vulnerable. This includes newborn 
infants as well as minors and those who are responsible for consenting on their behalf. 
Audits and inspections are carried out by regulatory agencies to ensure compliance with 
Good Clinical Practice procedures and applicable regulations.  
 
In Ireland the Health Products Regulatory Agency is responsible for such inspections. All 
clinical trials must also have an independent trial monitor who will oversee all aspects of 
the trial protocol including adherence to informed consent procedures.  
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The clinical trials which took place during World War 2 serve as a stark reminder of the 
importance of informed consent for all trial participants including those consenting on 
behalf of their loved ones. Sadly, examples of historical unethical research practices are 
still coming to light. As recently as 2014, a newspaper published an article describing 
unethical clinical trials involving almost 300 children residing in care home’s in Ireland 
(72). The article outlined the fact that it was suggested that informed consent was not 
sought from parents of these children.    
 
While positive steps have been implemented legislatively on a worldwide basis in relation 
to informed consent in clinical research, it is important that past atrocities remain in 
memory to serve as a reminder to all, of the potential horrors clinical research can inflict 
on human beings.  Adult, minor and proxy consenters involved in the consenting process 
must be treated with equal respect as that of a medical patient.  
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Chapter 3: Original Research  
 
Title: Perceptions of Parent(s) and Clinicians regarding the informed consent process in 
neonatal research in Ireland. 
 
3.1 Background information  
 
Informed consent is a core aspect of medical research involving humans. Apart from 
situations involving emergency research, it is a legal and ethical requirement that 
informed consent be obtained prior to any procedures taking place. Proxy consent must 
be sought from parents or guardians for any type of research which involves their 
newborn infant. For the remainder of this chapter I will refer to parents and guardians as 
parents.  
 
Parents are usually approached with information about a neonatal study before or shortly 
after the birth of their baby. This can be an incredibly emotional and stressful time for 
parents, particularly if their infant is born premature or ill. According to Mason et 
al.(2000) questions have arisen as to whether the process of obtaining informed consent 
from parents for neonatal research leads to valid consent (14). 
 
McKechnie et al.(2006) reinforces this point highlighting that consent obtained from 
parents during times of extreme emotional pressure can fall below the expected 
requirements needed for informed consent to be considered valid (73). In Ireland minimal 
research has been completed to assess the validity of consent obtained in the neonatal 
period from parents of newborn infants.  
 
In its own guidelines the Health Service Executive (2013) states: 
 
“Consent is the giving of permission or agreement for an intervention, receipt or use of 
a service or participation in research following a process of communication about the 
proposed intervention” (6).  
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The purpose of this study is to explore the communication exchanged between parents 
and clinicians during the informed consent process in neonatal research, from an Irish 
hospital setting. As a result two questionnaires were developed including one 
questionnaire to be completed by parents and the other by clinicians. The questionnaires 
were drafted in a manner which allowed for various styles of replies from parents and 
clinicians. This included answers with a yes/no, free text answers and answers based on 
the likert scale.  
 
3.2 Aim and objectives of the study 
 
The aim of this study was to gather as much information possible from parents and 
clinicians regarding their views and experiences of the informed consent process in 
neonatal research from an Irish hospital setting, thereby allowing one to identify the 
strengths and weaknesses of the consenting process. This will allow the neonatal 
community to explore and ultimately improve upon this process. 
 
My research objectives were as follows; 
 
1. To explore into the communication exchanged between parents and clinicians 
during the informed consent process to neonatal research, from an Irish hospital 
setting; 
 
2. To identify and discuss positive and negative experiences and opinions of the 
process, as described by those involved; 
 
3. To produce guidelines for clinicians to act as a guide for best practice 
procedures when gathering informed consent from parents; and  
 
4. To identify methods to increase the informed consent experience for all those 
involved.  
 
3.3 Inclusion Criteria 
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The table below describes the inclusion criteria for parents and clinicians. Only those who 
fulfilled the inclusion criteria were asked to complete the questionnaires.  
 
Table 4: Inclusion criteria - parents 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Inclusion criteria - clinicians 
 
 
 
 
 
3.4 Methods  
 
Questionnaire Development and data collection 
 
Overall, two questionnaires were developed for this study;  
 
Questionnaire 1: A questionnaire for parents entitled: Parental Perceptions of the 
Informed Consent Process in Neonatal Research. 
 
Inclusion Criteria – Parents 
Parents of infants born at < 37 weeks  GA.  
Parents of infants that had been admitted to 
the neonatal intensive care unit of the Cork 
University Maternity Hospital (CUMH) after 
birth. 
Parents who had been approached by 
clinicians/researchers information about a 
neonatal research study antenatally or after 
the birth of their infant. 
Parents who were attending the neonatal 
clinic with their infant after discharge from 
the hospital. 
Inclusion Criteria – Clinicians 
Clinicians currently employed in a hospital 
Ireland. 
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Questionnaire 2: A questionnaire for clinicians entitled: Clinicians Perceptions of the 
Informed Consent Process in Neonatal Research. 
 
Two information leaflets were developed in conjunction with the questionnaires.  
 
3.5 Parent questionnaire 
 
The parent questionnaire was developed with the assistance of Dr. Kieran Doran, senior 
law lecturer, University College Cork (UCC) and Professor Eugene Dempsey a consultant 
neonatologist based in the Cork University Maternity Hospital (CUMH). The input 
provided to me from Doran and Professor Dempsey was fundamental to ensuring that the 
content in the questionnaire reflected the sensitivity of the subject matter subject 
matter, namely sick newborn infants admitted to the NICU. As a result of this 
collaboration the questions and layout of the questionnaire were considered sensitive 
and appropriate for the vulnerable cohort.  
 
The questionnaire included both structured and semi structured questions. This was to 
allow answers to be varied. Some answers had to be yes/no, some were based on the 
likert scale and some were free text. This was to maximise the variety possible responses, 
thus ensuring the highest content and quality of replies. It was our hope that this 
approach would also increase the likelihood of identifying novel information relating to 
parents views and experiences of the informed consenting process  
 
The parent questionnaire contained a total of 26 questions divided into three sections; 
background information, parent’s own experience of the informed consent process and 
finally the questionnaire sought information relating to the specific research study 
parents were asked to enrol their baby to.  
 
Section 1 - Background information  
 
This section looked for basic demographic information from respondents. Questions 
related to gender of respondent, marital status, level of education and gestational age of 
their infant at birth. It was necessary to obtain basic background information from 
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respondents to able to locate and correlate any trends resulting as a result from the data 
acquired from the completed questionnaires.  
 
Section 2 - Parents experience of the informed consent process  
 
The aim of this section was to gather as much information possible from parents relating 
to their views and experience of the informed consent process. A wide range of questions 
were incorporated in this section. Questions with likert scale answers, free text answers 
and yes/no answers were included. The aim of section two was to gather a general 
overview including both positive and negative experiences, parents had of the informed 
consent process. We also endeavoured to seek out the preferences parents had in 
relation to different aspects of the informed consent process in neonatal research.  
 
Questions with yes/no answers sought to gather information general information relating 
to the uptake of consent, the availability of information leaflets, the amount of neonatal 
studies parents were asked to consent too and finally, any issues parents had relating to 
their level of comfort about discussing concerns with researchers.   
 
Questions using the likert scale had a set range of five different answers, starting at 
“strongly disagree” and finishing at “strongly agree”. The aim of the scale was to rate 
parents level of agreement to various statements. Questions explored parents views of 
the timing of consent, their level of understanding of information received, the 
voluntariness of consent and their level of concern regarding their infants participation in 
the study.  
 
The goal of the questions with free text answers was to extrapolate any information 
relating to the level of comfort parents had about relaying concerns to researchers and 
describing reasons for refusing consent.  
 
Section 3 - Research project 
 
This section related to the research study for which parents were asked to consent. The 
main goal of section three was to assess parent recall of information received at the time 
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of consent and also to assess the validity of consent based on questions included in this 
section. Parents were asked to include any details they could recall about the study their 
newborn infant took part in. I also sought their views in relation to audio recording the 
consenting process and their feelings on a waiver of consent. Finally, parents were asked 
based on their experience of informed consent in neonatal research, would they take part 
in future studies?    
 
3.6 Clinicians questionnaire 
 
The clinician’s questionnaire consisted of 22 questions divided into two sections. The 
design and format of the questionnaire was similar to the parent questionnaire. The 
questionnaire included various types of questions designed to maximise the strength and 
diversity of responses. Questions with yes/no answers, questions based on the likert scale 
and questions with free text answers were all incorporated.  
 
For questions with likert scale type answers two different five  point scales were used; 
scale one allowed respondents to rate their level of agreement to the importance of 
various statements (starting with “very important” and ending with “unimportant”, scale 
two rated the level of agreement respondents had with various statements starting with 
“strongly disagree” and ending with “strongly agree”. 
 
Section 1 – Background 
 
Section one was designed to explore into the experience clinicians had of the informed 
consent process in neonatal research and also their views relating to various features of 
this process. Questions designed to gather information related to the clinicians 
background, experience with GCP and informed consent training were also included.  
 
Section 2 – Consenting process 
 
The goal of this section was to explore into the personal viewpoint clinicians have of the 
informed consent process within neonatal research. I sought to examine their approach 
to the consenting process including how much time they typically spend with parents 
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during the consenting process, their views of parents understanding of information 
received during the consenting process, their views relating waiving of consent and the 
necessity of signed consent forms. 
 
3.7 Research setting 
 
The majority of the study took place exclusively in the Cork University Maternity Hospital, 
Wilton, Cork. The CUMH is the second largest maternity hospital within the EU. It caters 
for approximately 9,000 live births per annum with roughly 15% of the babies entering 
the Neonatal Intensive Care Unit.  
 
This included recruitment of parents and clinicians, data storage, data entry and data 
analysis. 
 
3.8 Ethics approval 
 
I submitted an application to the Research Ethics Committee of the Cork Teaching 
Hospitals (CREC) on the 12 December 2014. The following documents were included in 
the application: 
 
1. CREC Cover letter 
2. Parent questionnaire 
3. Parent information leaflet 
4. Clinicians questionnaire 
5. Clinicians information leaflet  
6. CREC application form  
 
These documents can be located in appendix A of this dissertation 
 
Permission to begin the study was granted from the committee on the 17th December 
2014. No queries or issues arose from the committee in relation to the application. 
Recruitment for the study began in February 2015.  
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In the end of April I had the opportunity to distribute my anonymous questionnaire to 
approximately 25 clinicians who were attending a neonatal training seminar conducted by 
Professor Eugene Dempsey. To allow for the inclusion of the questionnaires completed by 
these clinicians I submitted a letter to the CREC on 06 May 2015.  
 
At this time I specifically requested permission to access clinicians based outside of Cork. 
While this request was granted by the committee on the 22 May 2015, the approval letter 
specifically granted me approval for clinicians working in Cork, Kerry and Limerick, thus 
excluding a number of clinicians recruited at the neonatal training seminar. To rectify this 
I submitted a new letter and amendment request form to the committee on the 15th June 
2015. This request was granted by the CREC on 25th July 2015.  
 
There were no further issues in relation to the ethical aspect of this study. 
 
3.9 Recruitment   
 
I recruited two separate groups to this research study; a parent group and a clinician 
group.  
 
Group 1 recruitment: Parents of infants admitted to the NICU in the CUMH and 
subsequently discharged. 
 
Group 2 recruitment: Clinicians presently working in a hospital environment.  
 
3.9.1 Recruitment of parent group 
 
For this portion of the study I recruited parents attending the neonatal clinic of the 
CUMH. Infants who attend this clinic can be both new (post discharge from the hospital) 
or follow up appointments (up to approximately 2 years of age). I was provided with 
online access to the weekly appointment clinic lists to locate the infants attending clinic 
and to cross check their eligibility for this study.   
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A total of five clinics take place on a weekly basis. This number may decrease depending 
on the availably of the consultant neonatologists. The clinics are based on the first floor of 
the CUMH. The consultants will see between approximately five and 15 patients per 
session and each session typically can last between two and three hours. Parents who 
attend the clinics will check in at reception and wait to be called by the nurse, where their 
newborn infant will be weighed. After this parent(s) and their baby will return to the 
waiting area while they wait to be called into see a doctor.  
 
I approached parents with my questionnaire while they were waiting for their clinic 
appointment, and began recruitment in February 2015 in order to allow adequate time 
for data entry as well as analysis. Recruitment was completed at the end of May 2015.   
 
3.9.2 Recruitment of clinician group 
 
For this portion of the research study I recruited a total of 36 clinicians. Approximately 11 
clinicians, based in the CUMH were asked to complete the questionnaire during a weekly 
teaching session in the CUMH. The remaining clinicians completed the questionnaire 
during a teaching seminar in Dublin.  
 
3.10 Recruitment challenges 
 
The biggest challenge I experienced related to recruitment of the parent cohort. At times 
it proved difficult to successfully locate and meet with parents attending the neonatal 
clinic. Parents are given a set clinic appointment time and upon arrival to the hospital, 
check in to the clinic and wait in the waiting area to be called to see the doctor  
 
Parents were approached while they were in the waiting area of the clinic. Occasionally 
parents did not attend their clinic appointment or, more frequently arrived to the clinic at 
incorrect times thus were not in the waiting room when I called into meet with them.  
 
Parents often arrived to their clinic appointment with their baby’s sibling(s). If a lone 
parent arrived with more than two siblings it may not have been feasible to ask them to 
complete the questionnaire.  
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Finally, I chose not to approach parents whose infant was discharged from the neonatal 
unit with a serious illness.  
 
I did not experience any major hurdles with regard to recruitment of clinician cohort bar 
receiving an approval letter from the CREC limiting my contact with clinicians to Cork, 
Kerry and Limerick. However once I submitted a further amendment this issue was 
resolved without delay.  
 
3.11 Data collection  
 
Parent group  
 
Of the 49 of parent(s) I approached to complete the questionnaire, none declined. In a 
few cases both parents completed the questionnaire together but it most circumstances 
one parent completed the questionnaire whilst the other looked after their infant (and 
sibling(s). It was documented where parents completed the questionnaire together. In 
just one case a couple (mother and father) completed a questionnaire separately. I 
gathered a total of 49 completed questionnaires however I excluded 6 from data analysis 
as mothers were more than 37 weeks into their pregnancy.  
 
Clinician group 
 
In total 36 clinicians based in an Irish hospital setting completed the questionnaire.  
 
3.12 Statistical plan  
 
All data analysis was performed using the statistical programme IBM SPSS statistics 
version 22.  
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Chapter 4: Results 
 
4.1 Parent questionnaire 
 
A total of 49 parents (both mothers and fathers) completed the parent questionnaire. Six 
mothers and were excluded from the analysis portion of the study as they did not meet 
the inclusion criteria of <37 weeks gestational age at birth. The gestational age of the 
excluded women ranged from 37 to 40 weeks. 
 
Parents approached to take part in neonatal research whilst their newborn baby was an 
inpatient in the NICU but declined consent sections of the questionnaire which were 
relevant to them.  
 
Section 1 of questionnaire: 
 
Background 
 
In total 8 fathers and 33 mothers completed the questionnaire independently. Two 
questionnaires were completed by parents jointly. In the analysis portion of the study 43 
questionnaires in total were included.  
 
Approximately 77% of parents who completed the questionnaire were married, 19% co 
habiting and 5% were single parents. The gestational age at birth of mothers ranged from 
25 weeks to 36 weeks GA.  
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Figure 1: Gestational age in weeks at birth 
 
Figure 1 outlines the minimum and maximum gestational age of babies born. The 
minimum gestational age at birth was 25 weeks and the maximum gestational age at 
birth was 36 weeks. 
 
A total of 8 parents attended secondary school level education and 32 attended third 
level education. Of a set of parents who completed the questionnaire together, one 
attended secondary school level education and one attended third level education 
although it is not clear who completed which level.  
 
Section 2 of questionnaire: 
 
In this section of the questionnaire parents were asked a series of questions related to 
their recall and experience of the informed consent process.  
 
When asked if they could recall who had approached them with information about a 
neonatal study 41% (n=14) were approached by a consultant, 32% (n=11) by a junior 
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doctor and 26% (n=9) stated ‘other’. Some parents who completed the free text section 
wrote that they were approached with information to a neonatal study from various 
clinical and research staff including registrars, nurses, research nurses, researchers and 
students.  
 
In one case a mother stated she was approached by a consultant, junior doctor and 
research nurse at different times prior to consenting. Another mother was approached by 
a consultant along with a junior doctor with information about a neonatal study and a 
third mother was unsure of who had approached her with information about a neonatal 
study. This mother chose not to consent her newborn infant to the study.  
 
Parent views of antenatal consent versus postnatal consent 
 
Parents were asked a series of questions relating to their views of being approached with 
information about a research study either antenatally or postnatally and for their 
individual experiences of either approach.  
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Figure 2: Overview of parents approached with information about a study either 
antenatally or postnatally. 
 
A total of 33% (n=14) of parents were approached with information about a neonatal 
study prior to the birth of their baby, 63% (n=27) were approached with information after 
the birth of their baby and 5% (n=2) were approached both before and again after the 
birth of their baby.  
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Figure 3: Five point scale measuring parents preferences to antenatal consent. 
 
Parents were asked if they would rather be approached with information about a 
neonatal study before the birth of their baby. 59% (n=24) of parents agreed or strongly 
agreed (34% and 24% respectively) to this statement, 33% (n=13) remained neutral and 
the minority of 10% (n=4) disagreed or strongly disagreed (5% and 5% respectively). 
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Figure 4: Five point likert scale measuring parent preferences to postnatal consent. 
 
Parents were subsequently asked if they would rather receive information about a 
neonatal study after the birth of their baby. 40% (n=17) agreed or strongly agreed (21% 
and 19% respectively), 33% (n=14) remained neutral and 26% (n=11) disagreed or 
strongly disagreed (19% and 7% respectively).  
 
Parent understanding of information received about the study  
 
92% (n=38) of parents received an information leaflet detailing the study for which they 
were asked to consent their newborn baby into. Parents were asked to rate their level of 
agreement to a series of statements about to their experience of the informed consent 
process;l 
 
Statement 1. “The information I received about the research study was clear and I fully 
understood it” 
 
68 
 
86% (n=36) of parents agreed or strongly agreed (57% and 29% respectively) that they 
had clear understanding and full comprehension of the research study.  
Consent   
A total of 83% (n=33) of parents gave consent for their newborn baby to take part in a 
neonatal study. Parents who declined were asked if they could recall their reason. This 
free text question was completed by a total of five parents.  
Parent 1: was approached with information about a study postnatally while his wife was 
in the high dependency unit in the CUMH. Once the trial was explained to his wife she 
remained unsure of the full process and therefore was not comfortable going ahead with 
the study.  
Parent 2: refused consent as she was hoping to be discharged from the hospital that day.  
Parent 3: traumatic time for them as parents and difficult to make decisions about their 
newborn infants welfare at such a time.  
Parent 4: outlined illness severity at the time of the consent for a reason for refusal.  
Parent 5: parents had concerns over the effect participation in the study would have on 
their very premature baby. 
Parents who gave consent for their infant to take part in a neonatal study were asked to 
elaborate on the reason why. A combined total of 96% (n=32) of parents agreed or 
strongly agreed (24% and 73% respectively) that they allowed their infant participate as 
they want to help babies born in the future. 
A combined total of 72% (n=28) of parents agreed or strongly agreed (39% and 33% 
respectively) that their baby’s healthcare would directly benefit from participation in the 
study. 
A combined total of 71% (n=27) of parents disagreed or strongly disagreed (48% and 26% 
respectively) that they felt obligated to take part in the study.  
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A combined total of 82% (n=31) of parents disagreed or strongly disagreed (50% and 32% 
respectively) that they felt pressure to take part in the study.  
When asked about their decision to enrol their newborn infant to a neonatal study 60 % 
(n=25) of parents made the decision alone. Those who did have assistance with decision 
making specified in free text who helped them; answers included consultants in the NICU, 
doctors from the research team, husbands, fathers, partners, research nurses, nurses and 
midwives.  
85% (n=29) of parents received a copy of the consent form after they had signed it.  
In the following section parents were asked to rate their level of agreement to various 
statements relating to the consent process and neonatal study.  
The results are outlined below. 
Statement 1  
“I knew my baby’s consent was entirely voluntary and that I could withdraw from the 
research study at any stage”.  
o 90% of parents agreed or strongly agreed (41% and 49% respectively) to 
statement one.   
Statement 2  
“I had no concerns for my baby’s clinical care if I decided not to take part in the research 
study”. 
o 83% (n=34) of parents agreed or strongly agreed (39% and 44% respectively) to 
statement two. Two parents discussed any fears had in relation in relation to 
refusing consent with researchers.  
Statement 3  
“I felt being asked to participate in a neonatal research study added extra stress at this 
time in my life”.  
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o The majority of parents (78%) (n=32) strongly disagreed or disagreed (27% and 
51% respectively) to statement three.  
19 parents were asked for consent to more than one neonatal study. Discussion regarding 
alternative treatment for non consenting babies was discussed with a total of 8 parents.    
 
Statement 4:  
 
“Researchers should have guidelines to follow which would recommend situations when 
it is not advisable to approach parents for consent to neonatal research”? 
 
85% (n=33) of parents agreed or strongly agreed (59% and 26% respectively) to 
statement four.  
 
Section 3 of questionnaire: 
 
Research Project 
 
This section focused on parent recall of details of the research studies parents were 
asked to consent to their newborn infant to. A total of 60% (n=22) of parents had 
recollection of certain details of the study they were asked to consented their infant to. 
In the free text section parents included brief statements to reflect recollection of the 
studies such as ‘brain activity’, ‘brain monitoring’, ‘breast milk research’ ‘breast milk for 
preterm infants, NIRS and C02 monitoring in resus’, ‘collection of stool samples’, ‘CPAP’, 
and ‘effect of the use of CPAP for the parents’.  
 
When asked if they would recommend having the informed consent process audio 
recorded a total of 6 parents stated yes with the majority (29) saying no.  
Parents were then asked to choose from a list outlining the various types of neonatal 
studies which are ongoing in the CUMH. The aim of this question was to choose the type 
of research which most described the study their infant took part in. 16 parents said their 
infant enrolled to a medical device study, four parents said they enrolled their baby to a 
71 
 
drug study, 19 said they enrolled their baby to an observational study and three parents 
said they enrolled their baby to a randomised study.  
Parents who gave consent for their newborn baby to take part in a randomised study 
were asked to write down any details they could remember of the randomisation process. 
This was a free text answer. Three parents completed this question however one parent 
who completed the question did not tick the relevant box in the previous section. Parent 
one included the following text ‘daily infusion of infloren with food (tube fed), parent two  
included ‘ monitors attached to the body and head for a period of 24 hours and repeated 
again in a few weeks’ and parent three included ‘some kind of monitoring’.  
76% (n=28) of parents disagreed with the concept of a waiver of consent. Finally, 87% 
(n=33) would take part in future studies based on their experience of neonatal research 
within the CUMH.    
 
4.2 Clinicians questionnaire 
 
Section 1 of questionnaire: 
 
Background 
 
The questionnaire for clinicians was completed by 36 clinicians; 25 of clinicians were 
senior house officers, 7 were specialist registrars and 4 were registrars.  
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Figure 5: Overview of clinical position of doctors completing the questionnaire 
 
7 clinicians were specialist registrars, four were registrars and 25 were senior house 
officers.  
 
A total of 12 clinicians had previous experience in the acquisition of informed consent in 
neonatal research. Of these, three had obtained consent to an interventional clinical trial, 
6 to a non interventional clinical trial and three to both interventional and non 
interventional neonatal studies.  
 
Informed consent training 
 
In this section clinicians were asked to rate their agreement to various statements 
relating to their opinions of informed consent. 
  
43% (n=15) of clinicians had received training in the acquisition of informed consent.  
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Figure 6: Rate of importance of informed consent training. 
 
75% of clinicians rated informed consent training as very important, 22% rated informed 
consent training as important and 3% rated informed consent training as moderately 
important. 
 
Clinicians were then asked if it should be an internal hospital policy that all clinicians 
involved in neonatal research receive study specific informed consent training. A total of 
89% (n=32) of clinicians strongly agree or agree (50% and 39% respectively) to the 
statement.  
 
Good Clinical Practice 
 
63% (n=22) of clinicians stated that they were familiar with GCP, 39% (n=14) had 
previously received training in GCP and 86% (n=30) rated training in GCP as either very 
important or important (43% each respectively).  
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Consenting Process  
 
 86% (n=31) of clinicians prefer to approach parents for consent to a neonatal study 
antenatally. Additionally 72% (n=26) of clinicians strongly agree or agree that approaching 
parents prior to the birth of their child leads to a greater uptake of consent (6% and 67% 
respectively.   
 
In relation to postnatal consent a small minority (11%) of clinicians strongly agree or 
agree that approaching parents after the birth of their child leads to a greater uptake of 
consent (3% and 33% respectively).  
 
81% (n=29) of clinicians believe parents do not fully understand the information they 
received at the time of consent. However, 52% (n=15) of clinicians stated they would 
proceed to allow parents consent their newborn baby to a study upon their insistence. A 
free text section allowed clinicians to document their reasons for this; 
 
Clinician 1: stated the belief that if parents had fully understood the study they 
would agree, therefore if every attempt is made to explain the study to parents 
and they somewhat understand, the clinician would accept consent.  
 
Clinician 2: noted that parents should be allowed to enrol their infant if they ask 
questions which reflect the information provided.  
  
Clinician 3: although this clinician stated yes to allowing parents consent, they 
further clarified that this would depend on the study characteristics and further 
explanation may be required.  
 
Information Leaflets and consenting procedures 
 
67% (n=22) of clinicians read through the information leaflets they provide to parents 
during the consenting process. Clinicians were asked roughly how much time they spend 
with parents during the consenting process. Results are in figure 7 below: 
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Figure 7: Time clinicians spend with parents during the consent process. 
 
73% (n=19) of clinicians spend less than 20 minutes with parents during the consenting 
process and approximately 27% (n=7) spend between 20 and 40 minutes.  
 
77% (n=20) of clinicians believe they spend enough time with parents to obtain valid 
informed consent and 32% (n=8) take contemporaneous notes during the consenting 
process.  
 
90% (n=29) of clinicians are not in favour of audio recording the consenting process.  
41% (n=13) of clinicians stated they approach parents at various stages throughout a 
study to ensure a continuous consent. 83% of clinicians strongly agree or agree that a 
signed consent form should be a prerequisite for all types of neonatal research (39% and 
44% respectively). 
 
Randomised trials and waiver of consent  
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A total of 6 clinicians had previously obtained consent to a randomised controlled trial. 
Clinicians were then asked for their opinion in relation to parental comprehension of the 
randomisation process.  
 
 
 
Figure 8: Do clinicians believe parents understand the randomisation process? 
 
In summary approximately 39% (n=14) disagreed, stating a belief that parents do not 
understand the randomisation process when explained to them at the time of consent, 
33% (n=12) remained neutral and approximately 28% (n=10) agree, believing that parents 
do understand the randomisation process when explained to them at the time of 
consent.     
 
To conclude clinicians were asked for their opinion in relation to a waiver of consent in 
neonatal research. 
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Figure 9: Likert scale measuring if clinician’s agree to a waiver of consent in neonatal 
research. 
 
In summary approximately 25% (n=9) disagreed, stating a belief that a waiver of consent 
is not appropriate in neonatal research, 19% (n=7) remained neutral and approximately 
56% (n=10) agree that a waiver of consent is appropriate in certain types of neonatal 
research.   
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Table 6: Waiver of consent in neonatal research. 
 
To conclude clinicians were asked to specify the type of neonatal research for which they 
believe a waiver of consent to be appropriate. Results are summarised in the table below. 
 
Neonatal Study Yes (%) No (%) 
Interventional study involving a 
drug 
6 94 
Interventional study involving a  
medical device  
6 94 
Non interventional/observational 
study  
50 50 
Emergency research 19 81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
4.3 Discussion of study results  
 
The Parents of newborn infants who are admitted to the NICU have been described in the 
literature as vulnerable (74) (14) (33). A number of studies have been completed which 
explore into the perceptions parents have of the informed consent process in neonatal 
research (31) (40) (29). However, only a handful of studies exploring into the perceptions 
clinicians have of the informed consent process have been completed. This Irish based 
study sought to investigate into the perceptions that both parents and clinicians have of 
the informed consent process in neonatal research. The study also sought to gather as 
much information possible relating to their views and experiences of this delicate 
process.     
 
As described earlier, two questionnaires were developed for this research study. One 
questionnaire was given to parents and the other was given to clinicians. The 
questionnaires included questions and statements of a similar design and content. This 
was to allow for clear analysis and reporting of conflicting and/or crossover results. For 
example, both groups were asked for their thoughts in relation to the timing of consent. 
72% (n=26) of clinicians agreed that approaching parents with information about a study 
antenatally leads to a greater uptake in consent from parents. A total of 59% (n=24) of 
parents said they would prefer to be approached with information about a neonatal study 
antenatally. These results highlight that both groups have a preference toward antenatal 
consultations/obtaining consent antenatally.  
 
It is of interest to note that despite the expressed preference to antenatal consultations 
as described by both groups, in this study a total of  29 parents from the parent cohort 
were approached with information about a neonatal study after the birth of their baby. 
This was this is despite the fact that many clinicians in the clinical cohort of the study 
expressed a preference to antenatal consultation. There may be several reasons as to 
why despite a majority preference to antenatal consultations, postnatal consent was 
sought more often than antenatal consent. Mothers/unborn may have been severely ill 
prior to birth thus making it unethical to approach for antenatal consent. Capacity to 
consent may have been compromised due to the severity of illness for mother and/or 
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unborn and finally, there may not have been enough time to obtain consent antenatally 
from parents. This tends to be the primary reason..   
 
It would be helpful to parents of newborn infants and to the neonatal research 
community to further explore what factors clinicians take into consideration when 
making a decision about when to approach for consent, and to establish in what 
circumstances parents believe that they should or should not be approached for consent, 
and when. This information could hopefully assist with the establishment of a general 
consensus for clinicians as to the most appropriate time to approach parents with 
information about a study. This in turn may help to increase the overall numbers of 
parents consenting to neonatal studies.  
 
Consent to neonatal research 
 
There is a positive uptake of consenting parents to neonatal research studies within the 
CUMH. Of the 43 parents included in analysis portion of the study, 34 (79%) consented to 
their baby taking part in neonatal research study. A further five parents from the group 
excluded from the analysis portion also gave consent. In total of 39 parents out of a 
possible 49 permitted their baby’s inclusion to a neonatal study. When asked for details 
about who approached them with information about a neonatal research study five 
parents were unsure or could not recall who had approached them with information 
about a neonatal research study. The remaining parents gave a written description of 
who approached them with information. Overall the majority of parents could recall the 
specific clinical role of the person who approached them for consent.   
 
A breakdown of the roles of clinical staff responsible for obtaining consent from parents 
and the correlating numbers of parents who consented can be found in table 7 on the 
next page: 
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Table 7: Parent description of clinical staff who approached them for consent to a 
neonatal study 
 
CUMH research staff  Number of parents who 
consented 
Consultant neonatologist 15 
Junior doctor 8 
Research nurse/nurse 2/2 
Researcher 3 
Consultant and junior doctor 2 
Consultant, junior doctor and 
nurse 
1 
Student 1 
Unsure/cannot remember 5 
 
 
These results show that consultant neonatologists working in the CUMH are heavily 
involved in the informed consenting process in neonatal research. One must question if 
parents find the extra contact with consultants a comfort during this difficult period in 
their lives?   
 
Interestingly this study found that the 10 parents who refused consent to a neonatal 
research study had been approached with information about a neonatal study a junior 
doctor not a consultant. This study showed that the majority of consent was obtained by 
a consultant, a fact that should be taken into consideration. It must be noted that 39 of 
43 parents agreed that their consent was entirely voluntary and they were aware of their 
right to withdraw their baby from a study at any stage. Results indicate that the vast 
majority of parents felt no coercion from clinicians and consent was voluntary.  
 
These results reflect a positive number of parents consenting to neonatal research 
studies. Consultant involvement during the consenting process should to be further 
increased. Parents/guardians should be afforded the opportunity to meet with 
consultants at some stage during the informed consenting process in neonatal research.  
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To ensure neonatal research studies are conducted in an ethical fashion and for consent 
to be considered valid it is essential that consultants ensure junior research staff receive 
adequate training in informed consent procedures. Research needs to be completed 
which explores into the validity of consent obtained by junior doctors, including research 
into the numbers of parents who consent /refuse consent to neonatal studies when 
approached by non consultant clinical staff.  
 
The parent questionnaire contained a ‘free text’ comment section that parents were 
asked to complete. Parents gave positive and negative reflections of their consenting 
experience. They also made recommendations to the process for future parents. One 
mother described how within 24 hours of being admitted to the hospital she was asked to 
take part in two studies and approached with information about four studies antenatally. 
She felt bombarded and was very worried about the welfare of her extremely preterm 
unborn baby. She recommended that consultants be present during all meetings between 
parents and clinicians regarding neonatal research studies.  
 
On a similar note another parent suggested the appointment of a liaison nurse who 
would be available at all times during the consenting process. It was also suggested that a 
separate room be made available for parents to engage in discussions about participation 
to research studies with research staff (away from general staff and population). 
 
From these results it would seem that consultant availability and support during the 
consenting process is essential for both parents and junior research staff. Consultant 
support may offer comfort to parents at such a difficult period of their lives. It may also 
assist them in their decision making process whilst affording consultants the opportunity 
to oversee the consent process junior research staff take part in and ultimately, oversee 
that a valid informed consent is obtained by junior research staff from parents.  
 
Some negative feedback from parents include one mother who believes discussing 
research participation after a traumatic labour is not appropriate; however she expressed 
no issue with antenatal consent provided mum is well. An interesting comment which 
emphasized the vulnerability of parents of newborn infants admitted to a NICU was from 
a father. While he praised the staff in the NICU it was his belief that parents do not 
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receive adequate guidance from hospital staff regarding the transitioning period of babies 
being a fulltime inpatient in the NICU to being discharged and at home on a full time 
basis. It is appreciated that this comment does not reflect the informed consent process 
or research participation however it is an important statement reflecting the need for 
increased home care guidance for parents of babies who are an inpatient in the the NICU. 
It is essential that comments of this nature are not ignored if we are to improve the 
experience parents in the hospital setting.  
 
One of the objectives of this study was to explore into the reasons why parents consent 
or refuse consent to neonatal research. When asked about their reasons for allowing 
their baby enrol into a neonatal study 97% (n=32) of parents stated their desire to help 
babies born in the future as a reason for giving consent. This altruistic intention has been 
expressed by parents as a motivating factor in giving consent to neonatal research in 
previous studies (26, 28, 30).   
 
A total of 72% (n=28) of parents believed that their baby’s healthcare would directly 
benefit from taking part in a neonatal study. It is a clinician’s duty to ensure that clinical 
care of patients/study subject precedes research procedures in all circumstances. 
Previous studies have shown that those who participate in clinical trials can have a better 
outcome than those who decline by virtue of their participation (75). However it is 
essential that despite this proven fact consent to research must remain entirely 
voluntary.  
 
In this study 71% of parents agreed that they did not feel obliged and 82% did not feel 
pressurised to take part in a neonatal study. These complimentary statistics highlight the 
element of voluntariness and of no coercion within this cohort. However a minority of 
parents did feel obligated and pressurised to give consent, thus rendering it impossible to 
refer to their consent as ‘informed’ or valid.    
 
Parents and clinicians were asked if they would like to have the informed consent process 
audio recorded. The majority in both groups said no.It is a documented legal requirement 
of clinical research that written consent be obtained from research subjects (including 
those consenting on behalf of others). However, written consent alone does not provide 
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evidence that full comprehension of a research protocol has taken place. While the 
majority of parents and clinicians in this study expressed that they would not like the 
consenting process to be audio recorded, it should be noted that audio recording the 
informed consent process could prove to be a useful tool for both clinicians and parents 
to monitor consent. It would allow clinicians to subsequently review the consenting 
process they took part in and if necessary hold further meetings with parents (if they feel 
this is required after review of the audio recording). In turn, parents could use the audio 
recording as a tool to help them with recall of information received during the consenting 
process. If audio recording of the consenting process is to be conducted appropriately it is 
essential to obtain consent from parents for the audio recording and from the local 
research ethics committee.  
 
A waiver of consent remains a controversial and ongoing subject in research. In certain 
circumstances a waiver of consent will be permitted by a research ethics committee (76), 
thus allowing investigators enrol research participants into a study without their written 
consent. In the US Federal Law permits a waiver of consent to a research study provided 
three conditions are met:  
 
1. the research must involve no more than a minimal risk to study participants;  
2. the waiver or alteration cannot not adversely affect the rights and welfare of the  
             participants; and 
3. it would not be possible for the research to be carried out without the waiver or  
             alteration (77).  
 
In this study 57% of clinicians agree that a waiver of consent is appropriate in certain 
types of neonatal research. However when presented with specific types of neonatal 
research for which a waiver of consent could be applied to (interventional drug 
trials/medical device trials, non interventional/observational research and emergency 
research) the vast majority of clinicians were opposed to a waiver of consent for all types 
of neonatal research with the exception of 50% (n=18) believing a waiver of consent to be 
acceptable in the case of non interventional/observational research.  
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76% (n=28) of parents expressed opposition to a waiver of consent in neonatal research. 
A total of 8 parents were in favour of waiving consent. It is interesting to note that the 8 
parents who were in favour of a waiver of consent to neonatal research had previously 
given consent to a neonatal research study whilst their newborn was an inpatient in the 
NICU. While this study did not specifically seek information from parents as to exactly 
why they are in favour or against a waiver of consent, it would have been worthwhile to 
have enquired from these 8 parents who had previously taken part in the consenting 
process, why they were in favour of a waiver of consent to neonatal research, having 
themselves taken part in the consenting process.   
 
Considering the contentious and varying opinions the medical and ethical community 
have in relation to a waiver of consent, it is suggested that further exploration into this 
sensitive area of informed consent be conducted, with parents who are at the heart of 
the process.  
 
The study sought to investigate into the amount if time clinicians spend with parents 
during the consenting process. 58% of clinicians spend less than 20 minutes in total with 
parents during the consenting process. A total of 76% of clinicians believe they allocate 
enough time with parents to acquire informed consent. It must be noted that the time it 
takes to acquire informed consent will vary from parent to parent. Consequently, it is 
essential that clinicians delegate as much time as they feel is necessary to obtain a valid 
informed consent from parents. It could be argued that a time frame of less than 20 
minutes is inadequate to fully inform parents of a sick newborn infant about, for example 
a randomised, controlled clinical trial. 
 
Parents who refused consent to a neonatal research study were asked if they could recall 
their reason for doing so. Statements relating to refusal of consent included the severity 
of illness of either mother and/or baby. One parent refused consent as she was hoping to 
be discharged from the hospital that day and one set of parents expressed concerns 
about the effect the study procedures would have on a very premature baby.   
 
This study endeavoured to find out if being asked to participate in neonatal research 
added extra stress to parents. The majority of parents (78%) (n=32) did not feel that being 
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asked to participate in neonatal research studies added extra stress to their lives. While 
these are encouraging figures it is suggested that further research be carried out in an 
effort to further minimise extra stress which some parents may feel as a result of being 
asked to participate in neonatal research studies.  
 
The majority of clinicians in this study do not continue to monitor consent for validity 
once obtained and do not make contemporaneous notes during the consenting process. 
It is therefore suggested that a consenting guideline be made available for clinicians to 
follow which incorporates other important aspects of consenting process such a checklist 
to ensure validity of consent and, due to the litigious nature of research, a policy on note 
taking during the consenting process.  
 
Information Leaflets 
 
The majority of parents in this study (93%) could recall receiving information leaflets 
about the study they were asked to consent their baby to and 85% (n=36) stated a clear 
understanding of the information contained in the leaflet. These results highlight a 
majority of parents receiving information leaflets and having clear comprehension of the 
information in the leaflet. All research related documentation which parents receive 
should be reviewed by a national ethics committee. It is of vital importance that 
researchers ensure information leaflets are drafted using language readable and 
understandable to all. Currently, it is common practice (and in most cases a requirement) 
to provide information leaflets to study participants during the consenting process. It 
must be noted that parents in this study who said they did not receive an information 
leaflet may not have had correct recollection of the consenting process as it may have 
been two years since their baby was in the NICU. Also depending on illness severity, 
parents may not recall receiving an information leaflet about a neonatal research study 
due to the trauma they were experiencing at that time.  
 
In an effort to assess recall of study information, parents were asked to write down any 
details they could remember about the study which they were asked to consent their 
baby to. In the ‘free text’ section parents included brief statements to reflect recollection 
of the studies. Statements included ‘brain activity’, ‘brain monitoring’, ‘breast milk 
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research’ ‘breast milk for preterm infants’, ‘NIRS and C02 monitoring in recus’, ‘collection 
of stool samples’, ‘CPAP’, and ‘to study brain development in very premature babies’. 
Although brief, the majority of descriptions given by parents did reflect the various 
research studies ongoing within the NICU of the CUMH at that time.  
 
However two sets of parents exhibited a lack of understanding for a research study they 
took part in. The first set of parent described the study as the ‘effect of the use of CPAP 
for the parents’. The other set of parents described the study as the ‘use of breathing 
monitors in addition to stethoscope following birth’. The research study they were 
referring to was in fact a RCT involving End Tidal CO2 monitoring. Newborn infants in this 
study were randomised to either quantitative or qualitative monitoring arms. Again it 
must be noted that a period of up to two years may have passed since these parents took 
part in the consenting process for that RCT. Both parents had consented to the trial. It is 
impossible to say if at the time of giving consent parents had full comprehension of the 
trial procedures or not.  
 
In this study 66% of clinicians read through information leaflets with parents during the 
consenting process. The majority of parents who took part in this study stated that they 
had full comprehension of the information contained in the leaflets. However it remains 
essential that clinicians take the time to read through information leaflets with parents as 
the amount of time which clinicians delegate to the consenting process may be difference 
between informed consent and just consent.  
 
In an attempt to determine the area which caused the greatest difficulty in understanding 
the information received during the consenting process parents were asked to choose 
from a list of possible reasons. One parent stated a language barrier as a reason for her 
difficulty in understanding information received during the consenting process, four 
parents had difficulty understanding the words used by the doctor when describing the 
study to them and three parents had difficulty understating the information provided in 
the information leaflet.  
 
Good Clinical Practice 
 
88 
 
According to ICH GCP (5); 
 
“The investigator should be aware of, and should comply with, GCP and the applicable 
regulatory requirements”. 
 
This study produced surprising and in some cases concerning results in relation to 
clinicians awareness of GCP. In total 62% of clinicians were familiar with GCP however 
only 38% of clinicians had received GCP training. A total of 12 clinicians who took part in 
this study had previously acquired consent to neonatal research studies from parents. Of 
these 12 clinicians, 6 were familiar with GCP and only five had received training in GCP.  
 
These results are interesting. The overall aim of GCP is to protect rights, safety and well-
being of trial subjects and also to ensure that clinical trial data is credible (5). GCP is a very 
well established guideline which in 1994 was transposed into Irish Law thus making it an 
offence to conduct oneself in a manner which is not in keeping with GCP guidelines. It is 
essential that investigators ensure that researchers/clinicians who are acting as co 
investigators receive training in GCP if a research study is to be conducted to applicable 
GCP law. It should also be noted that while a total of 85% of clinicians rated GCP training 
important, only 62% of the clinicians stated that they were familiar with it. It is suggested 
that for hospitals which conduct research, a policy enforcing GCP training to all new 
appointees should be made mandatory.  
 
Randomised trials 
 
Clinicians were asked if they were of the opinion that parents tend to fully understand the 
randomisation process when explained to them. 39% (n=14) agree that parents do not 
fully understand the randomisation process when explained to them and 29% (n=10) 
believe they do. The remainder of clinicians remained neutral on the subject.  
 
Parents were asked if they had given consent to a randomised study and if so, to write 
down any details of the randomisation process they could recall. Three parents had 
enrolled their baby to a randomised study and provided details. However the details they 
gave did not provide any information as to the randomisation process for which their 
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baby took part in. It is impossible to say if this is because parents did not have an 
understanding of the randomisation process when explained to them at the time of 
consent or if they simply could not recall the details of the process at the time of 
completion of the questionnaire.  
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Chapter 5: Conclusion and Future Direction 
 
The last 40 years has witnessed significant advances in neonatal care (78). The health of 
our future generation of newborns is directly intertwined with the performance of clinical 
research in which infants participate (78). The informed consenting process of research 
involving newborn infants raises many ethical issues. Clinicians involved in the informed 
consenting process must ensure that they adhere to the core ethical principles which 
govern research with human subjects. It is a legal and ethical duty of clinicians to ensure a 
valid informed consent has been given from the parents of newborn infants.  
 
One of the goals of this study was to systematically explore into the perceptions parents 
and clinicians have of the informed consenting process in neonatal research. It became 
clear from the literature review that in the last 30 years a far greater number of studies 
which explore the perceptions parents have of the informed consenting process have 
been complete, with minimal studies completed to explore the perception clinicians have 
of the process 
 
Literature review and original research study  
 
Many results noted in my original research study entitled “Perceptions of parent(s) and 
clinicians regarding the informed consent process in neonatal research in Ireland” support 
the results found in my literature review. Overall parents are very supportive of neonatal 
research and have expressed altruistic reasons for allowing their newborn infants to take 
part. This includes parents wanting to help future generations of sick, newborn infants. 
Parents also expressed a belief that their baby’s healthcare would directly benefit from 
taking part in a research study.    
 
Parents are aware of their own vulnerability during the neonatal period. They also 
acknowledged fellow parents vulnerability during this time. The majority of parents who 
took part in my study had consented to a neonatal research study and did not express 
regret of their decision. However parents who refused consent gave reasons such as the 
traumatic nature of their lives at that time and the inability to completely understand the 
study when explained to them. Parental confusion surrounding research protocols was 
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noted in my literature review. Additional correlating results between my literature review 
and questionnaire based study include parental opposition to a waiver of consent in 
neonatal research.  
 
Clinicians believe a waiver of consent is acceptable in the case of non 
interventional/observational research.   
 
On a positive note, the majority of parents who took part in my study did not feel coerced 
by clinicians/researchers to take part in neonatal research studies.  
 
During my literature search it was surprising to find only two studies available which 
explored into the perceptions clinicians have of the informed consent process in neonatal 
research. Both studies were interview based studies. My original study involved clinicians 
and parents completing a questionnaire.  
 
The results of the published studies and those of my original study had similar themes. 
For example parents in both the published studies and from my cohort both reported that 
alternative treatment for their newborns was not discussed during the consenting 
process. However for one study reported in the literature review the ability to withdraw 
from the study at any time was not overly discussed with parents during the consenting 
process. The results of my original study highlighted that the vast majority of parents 
were aware of their right to withdraw from a study at any time.  
 
Ethical and legal issues of informed consent in research 
 
The main focus of this chapter was to provide the reader with an overview of the ethical 
and legal issues of informed consent in research. This included examples of unethical 
conduct by researchers in the past. Unfortunately, as highlighted in the Tuskegee Syphilis 
Study when the core ethical principles which govern research involving human subjects 
are overlooked and ignored by researchers the results can be in devastating for those 
research subjects.  
 
92 
 
The regulations investigators must adhere to have become increasingly demanding. 
National Ethics Committees are now taking responsibility for the ethical conduct of 
research toward its study subjects. This includes reviewing and approving all 
documentation that study subject/proxy consenters will receive. This step ensures further 
adherence to the principles that govern human research.  However remains the 
responsibility of clinicians involved in research to adhere principles as outlined in the 
groundbreaking publication by Beauchamp and Childress (79).  
5.1: Future Direction  
 
In essence the process of informed consent is one of the main contributors of upholding 
ethical conduct throughout the lifecycle of a research study (80). The results of the 
research undertaken to complete this dissertation make suggestions regarding how to 
improve the informed consenting process for both parents and clinicians.  
 
Parents felt strongly that clinicians should have set guidelines to follow which would 
advise them of when, and in what situation, that they should not approach parents with 
information about a neonatal research study. One mother, approached with information 
about four separate neonatal research studies antenatally expressed how she felt 
bombarded whilst in the hospital. It is essential that clinicians minimise any further stress 
to parents where possible. Guidelines to assist clinicians in the consenting process 
including advising when to not speak to parents about neonatal research should be made 
available to clinicians and researchers throughout Irish hospitals.  
 
Results from the questionnaire study highlighted an increased need for consultant 
support during the consenting process for both parents and clinicians. One parent 
recommended that a consultant be present during all meetings between parents and 
clinicians regarding neonatal research. Another parent suggested the appointment of a 
liaison nurse and the availability of a consultation room for consenting discussions 
between parents and clinicians. The amount of consultant support given during the 
consenting process should vary in respect of the type of research study for which parents 
are asked to consent their newborn infant to. For example it would be highly 
recommended that a consultant be available during the informed consenting process to a 
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RCT involving preterm infants however, for non emergency observational research an 
appropriately trained junior doctor would be suitable.  
 
It is recommended that clinicians involved in neonatal research attend informed consent 
training seminars hosted by senior consultants with expertise in the acquisition of 
informed consent and finally, mandatory training in GCP should be introduced to 
hospitals nationwide to ensure clinicians involved in research have awareness of GCP and 
its applicable procedures.  
 
It is recommended that clinicians involved in neonatal research attend informed consent 
training seminars hosted by senior consultants with expertise in the acquisition of 
informed consent and finally, mandatory training in GCP should be introduced to 
hospitals nationwide to ensure clinicians involved in research have awareness of GCP and 
its applicable procedures.  
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C. Parent information leaflet 
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D. Clinicians questionnaire 
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E. Clinicians information leaflet  
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F. CREC application form  
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Appendix 2- CASP qualitative checklist 
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